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RÉSUMÉ 
Les membres de la famille Endonuclease IV (Endo IV) d'endonucléases 
apuriniques/apyrimidiques (AP), sont des enzymes multifonctionnelles impliquées dans 
la réparation de l'ADN. En effet, les enzymes endo IV chez E. coli et 
apurinic/apyrimidinic endonuclease 1 (Apnl) chez S. cerevisiae sont capables de traiter 
des sites abasiques et des extrémités 3' bloquées. Des études récentes ont révelé que les 
AP endonucléases peuvent non seulement agir en tant que 3' ~ 5' exonucléases, mais 
participent aussi à l'incision de certaines bases oxidées. Jusqu'à présent, peu de 
connaissances existent au sujet d'APN-l de C. elegans (CeAPN-l); le premier 
homologue retrouvé chez un organisme multicellulaire. Nous avons développé un 
système d'expression chez la levure permettant de produire CeAPN -1 fusionnée à 
l'étiquette GST, et de la purifier à l'homogénéité pour une caractérisation approfondie. 
À l'aide d'essais in vitro, nous avons confirmé que, tout comme ses homologues, 
CeAPN -1 possède les activités AP endonuc1éase et 3' -diestérase. Pourtant, on a pu 
démontrer par la complémentation inter-espèces que les variantes E97G et E143G de 
CeAPN-l ne confèrent aucune résistance à une souche de levure déficiente en AP 
endonucleases lors d'un traitement aux différents agents d'endommagement à l'ADN, 
tels que le MMS, le H20 2 et la Bléomycine. Ces résultats confirment des observations 
antérieures lors de la substitution de résidus chargés dans un des quatre domaines 
conservés d'Endo IV liée à l'activité. Cependant, on a révélé que l'activité enzymatique 
de CeAPN-l semble être stimulée en présence d'une composante thermostable. Cela 
peut suggérer l'implication d'un inducteur ce qui différencie CeAPN-l de ses 
homologues. 
Mots Clés: CeAPN-l, Endo IV, AP endonucléases, site AP, réparation par excision de 
bases, réparation de l'ADN, C. elegans. 
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ABSTRACT: 
Proteins of the Endonuclease IV (Endo IV) family of AP endonucleases have 
been weIl documented for their multifunctional capacities in DNA repair. Studies with 
the E. coli endo IV and S. cerevisiae apurinic/apyrimidinic endonuclease 1 (Apnl) have 
demonstrated that these enzymes have the ability to process abasic sites and 3' -blocked 
ends. Additional investigations have revealed a capability to act as 3' -7 5' -exonucleases 
and, furthermore, have exposed a participation in the incision of certain oxidatively 
damaged bases. To date, very little is known of APN-l (CeAPN-l), the corresponding 
C. elegans Endo IV prote in and the first structural homologue to be found in a 
multicellular animal model. In this study, we have engineered an expression system in 
yeast to produce a CeAPN-l fusion protein and subsequently, purified the polypeptide 
to homogeneity for characterization. We confirmed, through in-vitro assays, that 
CeAPN-l also possesses AP endonuclease and 3'-diesterase activities as its 
counterparts found in unicellular models. Moreover, domain function analysis has 
revealed that the introduction of the CeAPN-l variants, E97G and E143G, in a yeast 
strain lacking AP endonuclease activity is unable to restore parental resistance when 
exposed to the DNA damaging agents MMS, H20 2 and Bleomycin. These results 
coincide with previous observations made following the substitution of charged residues 
contained in one of the four conserved domains of Endo IV affecting activity. However, 
unlike its homologues, we showed that the enzymatic activity is enhanced by a heat 
stable component. This suggests a likely key feature which differentiates this protein 
from other counterparts, despite structural and functional homology. 
Key Words: CeAPN-l, Endo IV, AP endonuclease, AP site, base excision repair, DNA 
repair, C. elegans. 
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1. INTRODUCTION AND LITERA TURE REVIEW 
DNA is victim to continuous attack. Mutations, being products of DNA damage 
and subsequent genomic instability, have serious consequences to a given cell. From a 
human perspective, the inability to counter various insults affecting DNA integrity has 
been correlated to cancer, aging, and multiple disorders [1]. Interestingly, DNA damage 
can stem from both exogenous and endogenous sources. Thus, exogenous sources 
(environment and mutagenic chemicals) include ultraviolet and ionizing radiations as 
weIl as a plethora of toxins and chemicals. In contrast, endogenous sources of DNA 
damage primarily include reactive oxygen species (ROS) which arise from metabolic 
byproducts [2]. Each source manifests itself by causing specific types of modifications 
to ultimately harm the normal state of the nucleic acid macromolecule. Thus, common 
insults affecting the double helix can be observed via base/sugar damage (hydrolysis, 
deamination, alkylation, oxidation, strand breaks, abasic sites), odd base mismatches or 
pairing (pyrimidine dimers) and strand cross linking [2]. 
1. Alkylated bases 2. Deaminated bases 
3 -Methyladenine 7 -Methyladenine Uracil 
3. Oxidized Bases 
o 
o~<Jt~H' 
8-0xoguanine (8oxoG) 
o 
OH~l 
"lN~ 
H 
5 -hydroxyuracil 
4. Other examples of Lesions 
N 
1 
<XN:lR 
1,NtS-Etheno-adenine 
2,5-Amino-5-
F onnamidopyrimidine (fapy) 
Thymine glycol 
5' 
3 ,N4-Etheno-cyto sine a-deoxyadenine 
Figure 1-1: Examples of Lesions Stemming from Altered Bases 
(adapted from [2,3]) 
2 
3 
A particular interest in this study would be devoted to the formation and repair 
of apurinic 1 apyrimidinic (AP) sites (shown below). These lesions (abasic) are 
characterized by a 10ss of the base component from the sugar phosphate moiety (se en in 
figures 1-2, 1-3, 1-4) [4]. These sitescan occur spontaneously (hydrolysis) and also via 
enzymatic means to remove damaged bases [4, 5]. 
~ ~ 
O~o_:;,---== ... =OyOH, Lo 
o 0/'-\ 
~ ~ 
Regular AP site 
5' 5' 
O)~OH r 
1 OH O~OH 
H 
o 
3' 
Reduced AP site 
o 
3' 
l' -oxidized AP site 
5' 
0= O~H 
o 
3' 
4' -oxidized AP site 
Figure 1-2: Different Forms of AP Sites (adàpted from [3]) 
1.1. Reactive Oxygen Species 
A primary source of endogenous cellular damage arises from oxidative stress. 
This results from an increased prevalence of oxidant molecules in the cell. Known as 
reactive oxygen species (ROS), these oxidant molecules are highly unstable due to an 
inherited unpaired electron [6]. Naturally, these reactive intermediates have an uncanny 
ability to react with electron rich components; notably, lipids, macromolecules and most 
importantly, DNA [7]. In fact, Fentonoxidants (i.e. Fe2+ + H202 -> Fe3+ + 'OH + ·OH) 
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are believed to be the most significant type of ROS causing DNA damage [2]. It should 
be stressed that changes made to the double helix structure require significant attention; 
hence, unlike other components, DNA cannot be tumed over or replaced with normal 
type molecules. Lesions formed due to oxidative stress are associated with base 
alterations which can result in 80xoG lesions, ring saturated pyrimidines, and also 
contribute to the formation of AP sites. ROS could also cause sugar fragmentation 
which can result in the formation of DNA strand breaks (with phosphoglycolate and 
phosphate blocked ends) [8]. 
ROS are produced through processes occurring during aerobic metabolism in the 
mitochondrion [6]. They can also be formed via a cell's interaction with exogenous 
sources, which may include ionizing radiation, UV radiation, carcinogenic compounds 
and anti-cancer drugs (Bleomycin, Neocarzinostatin) [9]. A cell can defend itself 
against ROS by exploiting antioxidant molecules and specific enzymes. A reduced 
capacity, if not an absolute failure, to counter DNA damage caused by ROS can easily 
hinder efficient replication and subsequently be highly mutagenic or otherwise, lethal 
[8]. 
1.2. DNA Repair Mechanisms 
In order to counter DNA damage, the cell has multiple DNA repair mechanisms 
which ensure survival. Thus, these include mismatch repair (MMR), direct reversaI 
(DR), double strand break repair (DSBR), nucleotide excision repair (NER), and also 
base excision repair (BER). Each repair pathway is responsible in countering specific 
types of lesions [2]. Undoubtedly, overlapping of the individual pathways is inevitable; 
thus, this phenomenon ensures substitute mechanisms in the repair ofDNA lesions [10]. 
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1.2.1. Mismatch Repair (MMR) 
The fundamental role of the MMR system lies in the removal of mismatched 
bases and the insertionldeletion loops that form during DNA synthesis [11]. It is a 
process that is highly conserved from prokaryotes to eukaryotes. MMR, in essence, 
involves the removal of a patch of nucleotides (similar seen in excision repair), 
followed by repair synthesis and subsequent ligation [12]. It should be noted that two 
forms of mismatch repair systems have so far been characterized: long patch mismatch 
repair and short patch mismatch repair. As a result, long patch MMR is capable in 
repairing a vast array of mismatche~ by excising segments up to 1 Kb long. On the other 
hand, short patches are characterized by an ability to handle only specific types of 
mismatches due to the fact that excision is restricted to a length of 1-10 nucleotides 
[12]. Recognition of mistmatches is carried through several enzymes which include 
MSH2 with MSH3 or MSH6. The complex allows the recruitment of a different group 
of proteins comprising of MLH1, MLH3, PMS 1 or PMS2. These prote in heterodimers 
allow the recruitment of other proteins implicated in the repair of the damaged strand 
[13]. Interestingly, defects in mismatch repair machinery in humans have been linked 
to the onset ofhereditary nonpolyposis colorectal cancer [12]. 
1.2.2. Direct ReversaI (DR) 
The direct reversaI system (DR) is thought to be the least complex of the DNA 
repair mechanisms. Unlike other pathways composed of multiple steps and 
subsequently, of multiple enzymes, the DR system involves a single step to remove the 
lesion in question. Hence, this type of quick reversaI is observed primarily when 
thymidine di mers (caused by UV) or methylated guanines are formed [12]. Several 
6 
moleeules have been eharaeterized as DR enzymes; thus, these include photolyases and 
MGMT (06-methylguanine DNA methyltransferase) among others [14]. The funetional 
role of photolyases in humans has not yet been clearly elueidated. However, the 
corresponding homologues in yeast and bacteria respectively, have shown a capacity to 
proeess damage caused by UV and cisplatin treatment. MGMT, on the other hand, is 
believed to be vital in processing lesions caused by alkylation [14]. Briefly, the alkyl 
group stemming from the les ion is removed and simultaneously shifted to the cysteine 
residue found in the active site of the protein. AIthough methyl transferases have shown 
to possess the ability to repair alkylated damage, the activity is known to be very energy 
costly. In fact, these DNA repair proteins are irreversibly inactivated following the 
enzymatic reaction and, subsequently, degraded by an ATP-dependent ubiquitin 
pathway [12]. 
1.2.3. Double Strand Break Repair (DSBR) 
Double strand breaks (DSB), as the name implies, refers to the fragmenting of 
both opposing strands making up the DNA helix. These particular lesions are 
considered to be fairly dangerous and, consequently, may lead to harmful genome 
rearrangements or translocations, if not properly processed [15]. As a result, double 
strand breaks are countered via two principle systems known as non-homologous end 
joining repair (NHEJ) and homologous recombination repair (HR) [16] 
Thus, in NHEJ, a specifie complex of proteins joins the two fragmented ends 
direetly without the presence of a homologous template. This process is thought to be 
most valu able in a pre-replication setting where no template is available [17]. NHEJ, in 
mammals, is initiated by a eomplex formed of MRE Il, RAD50 and MRN amongst 
7 
other proteins. This complex enables the activation of DNA dependent prote in kinase 
(DNA-PK) which phosphorylates several key proteins (histones). In the step, a 
particular DNA ligase, known as DNA ligase IV, associates with XRCC4 and XLF in 
order to seal the gap [18]. In contrast, homologous recombination does require the 
presence of a template (sharing homology to the damaged sequence) which is found on 
a sister chromatid (S or G2 phase)' and allows the strand to be restored [15]. 
Undoubtedly, the HR process is known to be very efficient in preserving the integrity 
, lu' 
and identity of the sequence [19]. In yeast, HR repair involves an initial complex of 
Mrel1, Rad50, Xrs2 as weil as specifie exonuclease enzymes; thus, the pathway is 
further mediated by Rad51 paralogs, Rad55 and Rad57. The final step (following 
resolution of the Holliday junction) requires, most notably, DNA polymerase and DNA 
Iigase [20]. 
1.2.4. Nucleotide Excision Repair (NER) 
The NER pathway is the major system utilized to counteract bulky DNA adducts 
or helix distorting modifications (i.e. 6-4 photoproducts and pyrimidine dimers) 
affecting long portions (2-20 bases) of a particular,'strand. Such lesions are formed via 
UV or specifie chemical agents (aromatic hydrocarbons, cisplatin) [21]. The repair 
process is composed of 4 general steps starting with damage recognition, pre-incision, 
damage excision, gap filling and ligation [22]. Nonetheless, NER is categorized into 
two sub-pathways: Global genomic (GG) NER and Transcription coupled (TC) NER. 
These sub-pathways are differentiated by the fact that GG NER repairs ail appropriate 
les ions in the genome; thus, including both transcribed and untranscribed segments of 
DNA. TC NER, on the other hand, processes damages encountered during transcription 
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where RNA polymerase becomes stalled at a helix distorting lesion (i.e. thymine dimer) 
[23]. 
1.2.5. Base Excision Repair (BER) 
The BER pathway is a vital mechanism composed of multiple enzymatic steps 
that encompass the repairing of damaged DNA bases and AP sites [2, 24]. Briefly, the 
pathway is initiated via a DNA glycosylase enzyme which recognizes and removes the 
damaged base in question (Fig 1-3). The excision of the modified base from the 
deoxyribose-phosphate backbone forms an abasic site (AP site), which is itself a form 
of DNA damage that requires prompt attention to prevent further mutagenic 
consequences [25]. It should be noted that the resulting base loss (AP site) can also 
occur through spontaneous hydrolysis. In any case, the AP site is processed by either an 
AP endonuclease or apurinic/apyrimidinic (AP) lyase activity (processes 3' side of AP 
site via cleavage between c-o bond within deoxyribose) [2]. Thereafter, the single 
nucleotide gap is filled and sealed via the sequential action of DNA polymerase and 
DNA ligase [25]. 
The identity of the glycosylase acting on a particular base is crucial in 
determining subsequent steps. In essence, glycosylases are classified under two subsets: 
monofunctional and bifunctional. The former subset (monofunctional glycosylase) 
possesses a single activity which allows it to excisè' the damaged base [26]. The single 
function glycosylase primes the AP site for AP endonuclease to act on the lesion. 
Thereafter, AP endonuclease incises 5' to the AP site and forms a 3'-OH and a 5'-
abasic sugar phosphate (deoxyribose-phosphate) [2]. In comparison, the bifunctional 
glycosylase is able to further process the AP site (AP lyase activity) itself by causing an 
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incision 3' to the lesion and forming a 3'-fragmented deoxyribose and a 5'-phosphate 
[27]. 
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Figure 1-3: Base Excision Repair (BER) Pathway (adapted from 
[28]) 
Diagram highlights important steps in BER, including the sub-pathways 
(short and long patch) invo1ved in mammalian cells. Damaged base is 
removed via either monofunctional or bifunctional glycosylase enzymes. 
The resulting AP site may be processed via AP endonuclease, forming a 
3'-OH and a 5'-deoxyribose-phosphate (5'dRP) via a 5' nick. The AP 
":;, ... 
site may also be countered through an AP lyase activity, which results in 
a 3' -unsaturated aldehyde. The short patch repair pathway involves 
formation of a single nucleotide gap via the removal of the 5' dRP 
(following AP endonuclease activity through 5'dRPase) and in addition, 
the resulting repair of the unsaturated aldehyde (via 3'diesterase activity 
of AP endonuclease). The long patch repair pathway is associated with 
the formation of a flap structure which is later enzymatically removed. 
Both short and long patch pathways involve sealing the single nucleotide 
gap via DNA Ligase l or the action of DNA ligase III and XRCC 1. 
Il 
12 
Activity E. coli S. cerevisiae Homo S. pombe C. elegans 
sapiens 
ung UNG UDG ungl ung-l 
alkA MAG MPG/AAG magl -
nth NTGl, NTG2 NTHl nthl nth-l 
jjJg OGGl,OGG2 OGGl - -
Glycosylase nei NEILl, - NEIL2 - -
mutY MYH myhl R13A5.9 - (wormdatabase) 
mutt - MTH pcdl ndx-l, ndx-2 
TDG -
AP xth APN2 APEl, APE2 apn2 exo-3 
Endonuc1ease nfo APNl not found apnl apn-1 yet 
polI RAD27 FENl rad2 crn-l 
- POL4 POLf3 pol4 -
holC F33H2.5, 
Post-incision, (X subunit) POL2,3 POLNE: cdc2O/cdc6 FIOC2.4 
Gap Filling & (wormdatabase) 
Sealing 
MIPl POLG mipl Y57AI0A.15 - (wormbase) 
polIII (fJ) POL30 PCNA pcnl pcn-l 
polIII (y) CDC44 RFC rfcl rfc-l (RFCl) 
ligA CDC9 LIGl,3 cdcl7 lig-l 
Table 1-1: Homologous BER Genes in Different Organisms 
Sequences were retrieved from gene databases (i.e. NCBI, wormbase, etc). 
http://www .nc bi.nlm.nih. gOY / 
http://www. wormbase.org/ 
http://www.genedb.org/genedb/pornbe/ 
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1.3. BER in Mammalian Cells 
The completion of the BER pathway in mammalian cells, following AP site 
processing, can either diverge into short patch repair or long patch repair (as shown in 
Fig 1-3) [28]. As a result, the short patch repair path is characterized by the replacement 
of a single nucleotide while its counterpart, the long patch repair system, is 
distinguished by the replacement of 2-13 nucleotides [29]. 
1.3.1 Short Patch Repair 
The short patch mechanism can be completed following either AP endonuclease 
or AP lyase action upon the AP site. In essence, the 5' deoxyribose-phosphate terminus 
created by AP endonuclease is processed via the deoxyribophosphodiesterase (dRPase) 
component of polp (DNA polymerase P) [29]. Thereupon, the 3' -blocked end created by 
the bifunctional glycosylase (AP lyase activity) is removed through the 3' -diesterase 
component of AP endonuclease (also bifunctional). The single nucleotide gap, formed 
in both situations, is filled in by polp and the resulting nick is ligated via DNA Ligase 1 
or the concerted action ofDNA ligase III and XRCCI [27] 
1.3.2. Long Patch Repair 
ln contrast to short patch repair, the long patch mechanism is only initiated 
following the action of monofunctional glycosylase and AP endonuclease. Long patch 
repair, in fact, has been usually associated with the processing of oxidized or reduced 
bases [30]. Hence, the 3' -OH group that results from AP endonuclease is extended via 
polymerase beta or delta/epsilon (polP or Blf..), and the joint action of proliferating cell 
nuc1ear antigen (PCNA) and replication factor C (RFC) [27]. The synergistic action of 
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these enzymes allows strand displacement to replace the missing nucleotides and forms 
an extensive flap structure (Fig 1-3). As a result, the formation of this structure primes 
the entry of flap endonuclease (FENI) which acts to cleave the flap [30]. FEN1 action 
causes a strand break which is in tum sealed by DNA ligase 1 (LIG1) or a complex of 
DNA ligase III and x-ray cross-species complementing ] (XRCC 1) [31]. Evidently, the 
long patch mechanism is differentiated from its counterpart (short patch repair) by the 
fact that it requires more wide-ranging machinery [27, 32]. 
1.4. BER in Saccharomyces cerevisiae 
Although the components of the BER pathway are fairly conserved, there are 
notable divergences that should be accounted in S. cerevisiae. In fact, contrary to what 
is observed in mammalian cells, pol~ homologues in S. cerevisiae have not been clearly 
documented in the literature. However, pol~-like nucleotidyltransferase domains are 
present in several yeast proteins (PoI4, Trf4, Trf5) [33]. It has been discovered that 
homologues of long patch repair proteins in mammalian cells such as PoIs (DNA 
polymerase s) (DNA repair synthesis) and Fenl (5'-flap endonuclease) are found in 
yeast as Pol2 and Rad27 respectively [10]. These findings indicate the presence of the 
long patch base excision repair pathway in yeast [33]. Recently, the discovery of Trf4 
in S. cerevisiae, a potential homologue of pol~ in mammals, possessing the 5' dRP lyase 
activity suggests that the short patch repair pathway may also co-exist to complement 
long patch repair in yeast [33]. 
In addition, coordination between the various proteins in yeast and mammals 
also appears to differ. This phenomenon can be illustrated, for example, via Ape land 
its reported direct interactions with the BER proteins, UDG and MYH (glycosyslases) 
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[34]. The human AP endonuclease (Apel) has also been revealed to play a role in 
regulating the function of several enzymes participating in the latter stages of the 
pathway; thus, these include FEN1, pol~, RPA, XRCC, PCNA and LIG1[34]. Studies 
have weIl exposed the complexities encompassing the Ape 1 prote in which go beyond 
its weIl characterized role in DNA repair. Thus, the mammalian protein has shown to be 
activated by thioredoxin which in turn, enables it to act as a redox factor. The redox 
component of Apel allows the protein to activate transcription factors such as activator 
protein 1 (AP-l) and nuclear factor KB (NF -KB) by maintaining specific cysteine 
residues in a reduced state [35]. Interestingly, Ape! has also been reported to be a 
strong activator of p53. These distinctive features associated with the mammalian AP 
endonuclease have not been clearly shown to exist in the corresponding yeast 
homologous proteins. It should be noted, nonetheless, that the 3-phosphodiesterase and 
3'-75' exonuclease activities of Apn2 have been revealed to be enhanced in the 
presence of PCNA [36]. Undoubtedly, differences associated between the yeast and 
mammalian homologues, become evident in the differing range of activities that they 
are composed of. Notably, Apn2, unlike its mammalian homologue Ape!, is not 
endowed with the ability to incise altered bases in a glycosylase independent manner 
(Nucleotide Incision Repair) [37]. 
1.5. BER in Schizosaccharomyces pombe 
Fission yeast distinguishes itself from its evolutionary counterpart, budding 
yeast, in the processing of AP sites. Most notably, the classical AP endonuclease 
members, Apnl and Apn2, have not been reported to being efficient in countering such 
lesions in fission yeast [38, 39]. In fact, it was found that the AP lyase activity of Nth 
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addresses this situation by producing blocked 3' -(l,~ unsaturated aldehydes [40]. The 
resulting 3'blocked ends finally promote the entry of Apn2 (major AP endonuclease) 
which repairs the blocked end via 3' -phosphodiesterase activity. It should be noted that 
Apnl and Uvel (minor AP endonuclease) act as a 'back-up' to Apn2 [41, 42]. 
Subsequent downstream events follow the traditional process of nucleotide gap filling 
and re-establishment of the phosphodiester bond [41]. 
1.6. BER Key Machinery 
1.6.1 Glycosylases 
As described earlier, glycosylases initiate the BER pathway by removing the 
modified base via cleavage of the N-glycosylic bond (linking base to sugar phosphate 
moiety). Glycosylases are known to be small monomeric proteins that, in general, 
function without the necessity of a particular cofactor [26]. The glycosylase farnily of 
enzymes is divided into two groups: monofunctional and bifunctional [10, 27]. 
1.6.2 Monofunctional Glycosylases 
MonofunctÎonal glycosylases are known to possess a single activity, which 
allows for the cleavage of the modified base. UDG, from E. coli, is reported to be the 
first DNA glycosylase to be characterized [26, 43]. Evidently, corresponding 
homologues can be found in S. cerevisiae and humans. The enzyme in question is fairly 
restricted in its specificity; thus, it has a strong ability to recognize uracil bases and 
closely related products (5-hydroxy-uracil) on DNA that may be formed as a result of 
the deamination of cytosine or misincorporation. [ 44]. 
17 
Another example of a weIl characterized monofunctional family is the Alkylbase 
DNA glycosylases, which excise alkylated bases resulting from both exogenous and 
endogenous sources [45]. These enzymes are known to be of wider specificity than its 
UDG counterparts. Members have been found in E. coli (AlkA), S. cerevisiae (MAG) 
and in human (MPG) [46-49] 
1.6.3. Bifunctional Glycosylases 
Bifunctional glycosylases possess an additional AP lyase activity (Figure 1-4) 
that is responsible for the hydrolysis of the 3' phosphodiester bond of the AP site by a !3 
or !3b elimination process generating a 3'a ~ unsaturated aldehyde [50]. This particular 
group of enzymes could be further divided on their ability to remove either oxidized 
pyrimidines or oxidized purines respectively [51l The former sub-group (excising 
pyrimidine bases) is represented by the Endo III-like glycosylases and could be found in 
E. coli (endo III or nth) , S. cerevisiae (Ntgl, Ntg2), S. pombe (Nth), and H sapiens 
(hEndoIII) [26]. 
An additional bifunctional glycosylase known as endo VIII has also been 
documented in bacteria. Thus, despite being functionally overlapping, endo VIII shares 
no sequence similarities with endo III. However, sequence similarities are observed 
when comparing endo VIII to Fpg [26, 52]. The latter sub-group, known as the Fpg 
family, characterized by the ability to excise oxidized purines, also has homologues in 
E. coli (Fpg), S. cerevisiae (Oggl) and hum an (a-hOggl and ~-hOggl). Fpg has been 
demonstrated to excise fapy-ade, fapy-gua and 8-oxoG (refer to Fig 1-1 for 
representation of lesions) [53]. Interestingly, despite having common substrate 
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specificity, the eukaryotic Ogg 1 is not closely structurally related to the bacterial Fpg 
[54] [26] 
1.6.4. AP Endonuclease Action in the Processing of AP Sites 
AP sites are known to be one of the most common spontaneous lesions that 
occur in DNA. 10 000 bases a day are 10st per mammalian cell [10]. In addition to 
spontaneous circumstances, the lesion is also formed by the enzymatic removal of a 
base which may have been damaged or misincorporated. Undoubtedly, AP sites are 
highly mutagenic and cytotoxic if not properly repaired [5]. In essence, the presence of 
AP sites can promote the blocking of transcription and replication [2]. 
+ 
Figure 1-4: AP Site and Resulting Repair (adapted from [55]) 
Diagram illustrating an AP site (represented by star notation) and the 
immediate processing which occurs to counter the lesion; thus, this may 
be achieved Via a 5' cleavage stemming from an AP endonuclease 
activity or through a 3' cleavage provided by an AP lyase activity. 
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Repair of chromosomal AP sites in bacteria has been indicated to be performed 
by BER and to a smaller degree by a series of additional mechanisms: NER, translesion 
DNA synthesis and recombination [56]. It must be stressed that the BER pathway 
serves as the most predominant and effective route for processing AP sites [10]. The 
key enzymes in countering AP sites are AP endonucleases. This particular group of 
enzymes, as mentioned earlier, is multifunctional; thus, it is composed of AP 
endonuclease and 3' -phosphodiesterase components [57]. Specifically, the AP 
endonuclease activity is responsible for the nicking of the sugar phosphate bond at the 
5' end of the AP site, producing 3' -hydroxyl group and 5' -deoxyribose phosphate. The 
3' -phosphodiesterase component, in contrast, is responsible for countering 3' blocked 
ends produced by free radicals. It may equally come into play to counter the end 
products of lyase activity (3' -ap unsaturated aldehyde) to subsequently enable the 
formation of the polymerase responsive 3' -OH [4, 58, 59]. 
AP Endonucleases have been traditionally categorized into two families, the Exo 
III and the Endo IV, which are structurally unrelated but generally perform the same 
function. The classic elements differentiating both families stem from the fact that Exo 
III homologues are Mg2+ dependent enzymes, readily inactivated via the addition of 
EDTA while, conversely, the Endo IV family is characterized by being Mg2+ 
independent [60]. Exo III members have been found in E. coli, S. cerevisiae, S. pombe, 
drosophila, C. elegans, mouse and human. The corresponding Exo III members in 
drosophila, mouse and human are thus far the sole AP endonuclease type found in these 
models. In comparison, Endo IV has been shown to exist in bacteria, yeast and worms 
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[55]. It should be emphasized that despite being associated in large part with the same 
function, both families of AP endonucleases have subtle variations in their effectiveness 
to counter certain les ions and differ in their overall activity within a given organism 
(highlighted in the next section) [61]. In particular, Endo IV enzymes, unlike the Exo III 
family, have an ability to repair lesions induced by specific oxidants (Bleomycin and 
tBR) [55, 61]. As a result, although not yet found, an Endo IV member in mammalian 
cells may exist due to its efficiency to process the se specific lesions refractory to Exo 
III. The existence of a mammalian Endo IV member may stern from a functional 
homology as oppose to a strictly structural one. Thereupon, examples of this type of 
relationship may be illustrated when investigating Fpg in bacteria versus Oggl in yeast. 
Although both enzymes in the corresponding organisms are not closely related in terms 
of structure, they do, in fact, share functional homology [26]. This thesis will focus 
primarily on the Endo IV family. 
1.7. Endo IV Family Members 
1.7.1 Escherichia coli en do IV 
Known to be a heat stable monomeric protein, endo IV is approximately 32 kDa 
ln size [60],[62]. It is a multifunctional enzyme composed of, among others, weIl 
established AP endonuclease and 3-diesterase activities [53]. Thus, endo IV can readily 
process DNA lesions consisting of 3'- phosphoglycoaldehyde, 3' -phosphate, 3'-
deoxyrobose-5-phosphate and 3' -hydroxy-2-pentanal [2]. Interestingly, it has also been 
comprised of endonuclease activity against DNA composed of urea residues [63]. 
However, endo IV is considered to serve as a 'back up' or the minor AP endonuclease 
to exo III in E. coli. Data has, indeed, showed that endonuclease IV was responsible for 
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only 10% of AP endonuc1ease activity in a bacterial cell. NaturaIly, the remaining 
proportion is attributed to exonuc1ease III [61]. Its expression was shown to be strongly 
induced in the presence of superoxide anions. In fact, it was reported that paraquat, 
plumbagen, menadione and phenazine metho sulfate , aIl known to form superoxide 
radical anions, could induce endo IV by 10-20- fold and, thus, enable the protein to 
attain a similar level as that of its counterpart exo III [64]. Hence, this induction effect is 
under the regulation of an intricate system involving the SoxR and SoxS proteins. 
Elevated levels of superoxide anions are reported to stimulate SoxR to later induce the 
expression of the SoxS protein, which in turn causes an increase in endo IV expression. 
It should be noted that the SoxRJSoxS proteins stimulate, in addition to endo IV, a 
significant array of components capable in restoring potential damage caused by 
unstable radicals [65]. 
Studies have showed that endo IV is endowed with additional activities to go 
along with the traditionally recognized components highlighted above. Although 
initially not detected, it was discovered that this enzyme comprises of a 3'75' 
exonuc1ease activity acting predominantly towards 3' recessed ends [66]. In essence, it 
serves as a proofreading activity allowing the removal of matching/mismatching 
nuc1eotides and altered bases (80xoG) at c1eaved ends [67]. Contrary to AP 
endonuc1ease activity, the exonuc1ease component appeared to be readily inhibited in 
the presence of EDT A and reducing conditions (ev en in the presence of DN A substrate) 
[60,66]. 
Structural analyses have revealed the presence of a tri-nuc1ear ZInC c1uster 
forming the active site which was demonstrated to play a crucial role in its biological 
activities. Two of the three zinc atoms are weIl buried and inaccessible to solvent. The 
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metal factors are coordinated to key amino acids which appear to be conserved across 
the Endo IV family [55, 68]. The presence of the zinc atoms was reminiscent of other 
similar c1usters involved in phosphodiester c1eavage. In fact, Pl nuc1ease in Penicillum 
citrinum and phospholipase C in Bacil/us cereus have revealed an ability to exploit the 
corresponding zinc c1uster to achieve hydrolysis of the phosphate bonds [68]. Structural 
studies involving endo IV have also disc10sed the existence of a TIM 
(triosephosphateisomerase) barrel fold which was identified to play a significant role in 
DNA binding and the recognition of AP sites. The TIM barrel has been characterized 
by a parallel configuration of eight ~ strands surrounded by eight a helices. The 
dynamics involved in catalytic action are thought to arise from the enzyme to bend 
DNA 90° and in the process, flip the abasic (AP) site [69]. The underlying structural 
features of the bacterial AP endonuc1ease parallels many characteristics observed with 
UVDE (UV damage endonuc1ease) [70]. Interestingly, UVDE plays a significant role in 
DNA repair by its ability to process UV -induced lesions but also acts as an AP 
endonuc1ease in certain organisms (N crassa, S. pambe) [70] 
Phenotype characterization has shown that a mutant lacking nia (gene encoding 
endo IV) is hypersensitive to the antibiotic Bleomycin (BLM). This particular anti 
tumor drug is an established DNA damaging agent which has been displayed to produce 
a series of single strand breaks forming 3' blocked ends (i.e. 3' phosphoglycolate DNA 
terminus), double strand breaks and the release of free bases from the sugar phosphate 
moiety [71-73]. Cunningham et al (1986) reported that the single mutant showed a 
slight increase in sensitivity to methyl methanesulfonate (MMS), an agent readily able 
to alkylate DNA bases (i.e. N3 position of adenine or N7 of guanine) and indirectly 
cause the formation of AP sites [5, 61, 74]. The partial sensitivity may be indicative of 
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the fact that exo III was still being expressed and, furthermore, en do IV is not the major 
AP endonuclease in bacteria. Interestingly, the strain was generally unaffected, in 
comparison to the wild type, to hydrogen peroxide, a potent oxidant known to cause 
single strand breaks with 3' phosphate blocked ends. The sum of these results contrasts 
to the situation where a single mutant lacking xth (gene encoding major bacterial AP 
endonuclease exonuclease III), in fact, displayed greater sensitivity towards MMS, 
hydrogen peroxide, near UV light and X-rays. However, sensitivity of the xth mutant 
was less dramatic in the presence of the oxidizing agent tert-Butyl hydroperoxide (tBH) 
and, furthermore, not reflected at aIl during BLM treatment [61]. The discrepancy in 
survival between both strains following BLM and tert-Butyl hydroperoxide (tBH) 
exposure illustrates that endo IV and exo III are not products of redundancy. 
Accordingly, a double mutant lacking nfo/xth demonstrated a synergistic susceptibility 
while under presence of alkylating agents (MMS) and oxidative agents (H202, BLM, 
tBH) [61]. As expected from the reported data, the overexpression of en do IV re-
established drug resistance (BLM, tBH) in an xth single mutant bacterial strain. 
Conversely, the overexpression of exo III in a strain void of an Endo IV member has yet 
to demonstrate a similar consequence in the presence of identical agents [75]. 
Undoubtedly, endo IV is endowed with greater versatility in countering specific types of 
lesions (revealed by BLM and tBH exposure) that exo III is unable to match. 
Additional studies have shed significant light to further the divergences that 
exist between endo IV and its exo III counterpart. For example, endo IV, unlike exo III, 
has been associated to a newly characterized mechanism complementing BER now 
known as Nucleotide Incision Repair (NIR). This pathway is differentiated by the fact 
that it is a glycosylase independent process, whereby the protein in question incises the 
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altered base and the deoxyribose component to subsequently promote eventual DNA 
synthesis. The NIR activity of endo IV allows the enzyme to process a diverse array of 
les ions stemming from oxidative stress: 5,6-dihydro-2'-deoxyuridine (DHU), 5,6-
dihydrothymidine (DHT), 5-hydroxy-2' -deoxyuridine, 2 ,6-diamino-4-hydroxy-5-N-
methylformamidopyrimidine and a-anomeric 2' -deoxynuc1eotides (adA and adT) [67]. 
Moreover, en do IV has also been associated with providing a protective effect to 
circumvent potential oxidative damage caused by UVB [76]. Unlike its counterpart exo 
III, endo IV is unable to directly repair the lesions caused by UVB. It should be noted 
that oxidative damage formed as a result of UVB irradiation is believed to be associated 
with AT to GC transitions and GC to CG transversions [76]. 
1.7.2. Saccharomyces cerevisiae Apnl (ScApnl) 
ScApnl has been reported to be the major AP endonuc1ease enzyme in S. 
cerevisiae. Data has revealed that it accounts for 97% of the AP endonuc1ease and 3'-
diesterase activity in the corresponding eukaryotic cell. The 42 kDa protein shares 41 % 
amino acid identity with the bacterial endo IV and composed of a similar zinc c1uster 
(3.3 atoms) found in the active site [77]. It should be stressed that like the bacterial 
endonuc1ease IV, ScApnl does not necessitate an additional metal co-factor for its 
reported activities. Moreover, ScApnl is able to act on a similar range of substrates as 
its counterpart in bacteria; thus, these inc1ude 3' -phosphoglycoaldehyde, 3' -phosphoryl 
groups and 3' -a,p-unsaturated aldehydes [2]. However, unlike en do IV, ScApnl is 
endowed with a longer C-terminal end which is in fact shown to be composed of 3 
important c1usters (c1uster 1, 2, and 3). These series of domains, rich in basic amino 
acids, have been elucidated to serve as an NLS. Cluster 1, in fact, was reported to being 
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essential for nuclear localization. Thus, the removal or replacement of cluster 1 may not 
affect enzyme activity in-vitro; however, it abolished the localization process to the 
nucleus. The substitution of cluster 1 with the NLS of SV40 (simian virus 40) did not 
appear to restore proper nuclear targeting. Furthermore, it was observed that neither 
cluster 1 or 2, on its own, was able to aIlow ScApnl to be signaled to the nucleus and 
moreover, the concurrent removal of both produced the same effect. Thus, it was 
postulated that cluster 1 and 2 behave as a bipartite NLS [78]. Experiments have shown 
that the bipartite cluster also plays a role in targeting the protein to the mitochondrion. 
In fact, this phenomenon appears to be mediated via an interaction with the protein Pirl 
[79]. In the absence of Pirl, ScApnl accumulates in the nucleus and cytoplasm. In 
contrast, deletion of a significant portion of the C-terminal domain contributes to 
subsequent accretion of the prote in in the cytoplasm only. [79]. 
Classical phenotypic analysis has revealed that ScApnl single mutants are 
hypersensitive to MMS (alkylating agent) as weIl as to the oxidants tBH and hydrogen 
peroxide. As expected, DNA coIlected foIlowing treatment with the particular alkylants 
and oxidants has showed a striking accumulation of DNA lesions. Spontaneous 
mutation rates of Apn 1 null mutants increased from 6 to 12 fold in comparison to the 
wild type [80]. Moreover, mutants have been correlated with a 59 foid increase in A.T 
to C. G transversion events [81]. The sum of these results displays the importance of 
Apnl in protecting the genome against a wide array of lesions. Nonetheless, the single 
Apnl mutant failed to show sensitivity following Bleomycin and Phleomycin treatment; 
thus, this piece of data contributed to the suggestion of a possible existence of an 
additional 3' -diesterase in Saccharomyces cerevisiae [80, 82]. Hence, Apn2 (Exo III 
family) was subsequently discovered and demonstrated to possess the same bifunctional 
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nature as its Endo IV counterpart. However, it should be noted that Apn2 remains the 
minor AP endonuclease in yeast [5]. As such, this conclusion rests on the evidence that 
an apn2 single mutant fails to demonstrate a dramatic hypersensitivity towards the same 
agents (MMS, H20 2) as was observed with the apnl mutant. The increased mutagenesis 
associated with single apnl null mutants reveal that Apn2 lacks the ability to optimally 
substitute for its AP endonuclease counterpart [5]. Double mutants void of both APNl 
and APN2 did, however, reveal an extensive sensitivity to MMS, H20 2 and Phleomycin 
that transcends what is observed with the respective single mutants [82] [5]. 
Recent investigations concerning Apnl have found that akin to its bacterial 
homologue, it also is composed of a 3'-75' exonuclease component which 
complements the well established AP Endonuclease/3-diesterase activities. Thus, this 
newly associated function is characterized by a strong preference for duplex DNA with 
3' recessed ends [67]. The exonuclease activity has been, interestingly, showed to 
permit the elimination of 80xoG lesions (formed at the 3' end of gap) resulting from the 
direct oxidation of guanine or a misincorporation by DNA polymerase. The ability of 
Apnl to process 80xoG residues prevents G.C to T.A transversions to become prevalent 
in oggl single mutants. As a result, it is believed that the Endo IV member in 
Saccharomyces cerevisiae may act as an alternative pathway to Oggl in the removal of 
80xoG from DNA. Apnl has also shown to reflect its bacterial homologue in its ability 
to take part in NIR and process a-anomeric 2-deoxynucleotides (adA and adT) and 
other oxidative lesions [67] 
ScApnl has recently garnered important attention in its potential benefit to 
humans. Thus, the expression of Apnl has showed an ability to counter damage 
instigated by ROS in the development of certain neurodegenerative diseases [83]. In 
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fact, the production of Apnl in mammalian ceUs revealed a decrease in sensitivity 
following oxidative stress [83]. 
1.7.3 Schizosaccharomyces pombe Apnl (SpApnl) 
Contrary to the situation in 8 cerevisiae, SpApnl is not considered the major 
AP endonuclease in S. pombe; a title which is rather held by Apn2. Contrary to the apn2 
mutant, data has revealed that the apnl mutant failed to demonstrate sensitivity to the 
alkylating agent MMS [39]. An additional minor AP endonuclease activity is found in 
8 pombe stemming from the Uvel enzyme, a previously established component of an 
alternate UV damage repair pathway to NER [42]. It has been reported by Fraser at al. 
that spontaneous mutations which occur in uvel null cells (8 pombe) are similar to the 
transversion mutations induced by 80xoG in S. cerevisiae. This evidence first suggested 
the role of Uvel in oxidative DNA damage repair in fission yeast [42]. However, 
SpApnl and SpUvel proteins were reported to possess AP endonuclease activity in-
vitro but failed to initiate AP site repair in-vivo [41]. As discussed earlier (section 1.6), 
the direct processing of AP sites in 8 pombe has been predominantly reported to be the 
domain of the Nth enzyme (bifunctional glycosylase) via its AP lyase activity 
(producing 3'C1.,~-unsaturated aldehyde ends) and not a member of either the Exo III or 
Endo IV families. The implication of such proteins, belonging to the respective AP 
endonuclease families, has thus far been restricted to the repair of 3' blocked ends 
(processed predominantly by Apn2, with Apnl and Uvel serving as back up 
components) induced in large part by Nth [41]. Undoubtedly, there are profound 
differences which exist between 8 pombe and 8 cerevisiae in the identity of the 
machinery having access to the lesions in question. These divergences are further 
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revealed through the expression and resulting complementation of ScApnl in the repair 
of both AP sites and blocked ends in mutant fission yeast strains (nthJ!j and apn2J!j 
single mutants) when exposed to MMS [41]. Interestingly, localization studies using 
GFP have revealed that SpApnl is distributed in the nucleus and, in addition, the 
cytoplasm (not observed with SpApn2); thus, suggesting that it may possibly play 
additional roles than simply being involved in maintaining genomic stability [41]. 
1.7.4. Caenorhabditis elegans CeAPN-l 
The gene encoding the C. elegans Endo IV AP endonuclease, CeAPN-I, was 
first identified following the utilization of a radiolabelled oligonucleotide (representing 
the sequence of yeast APN1) which was probed against a cDNA library of the 
multicellular organism [84]. The expressed prote in was initially reported to be 
composed of 396 amino acids but subsequent findings have reported that it is ev en 
larger (discussed below). Nonetheless, CeAPN-l shares considerable homology with 
Endo IV members found in the unicellular organisms highlighted. Hence, it shares 
40.4% identity with the yeast APNl and 44.9% identity with the bacterial nlo [84]. 
Much of the homology is concentrated in 5 distinct domains, thought to represent, 
notably, portions of the DNA binding domain and active site. Interestingly, C. elegans 
is the first higher eukaryote, representing an animal model, which has been reported to 
have both Endo IV (CeAPN-l) and Exo III (CeEXO-3) homologues. The latter 
member (CeEXO-3) has been weB characterized to being Mg2+ dependent and endowed 
with AP endonuclease/3' diesterase activities. However, it has also been found that the 
metalloenzyme is composed of a number of unique features which distinguishes itself 
from its Exo III counterparts; notably, a GST fusion CeEXO-3 protein failed to display 
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an important 3' -7 5' exonuclease activity following AP sites (opposite observed with 
bacterial and yeast homologues) and furthermore, it revealed to lack the ability to 
participate in Nucleotide Incision Repair (as observed with human Exo III, Apel) [85]. 
However, contrary to CeEXO-3, very little is known about CeAPN-l. Numerous 
attempts have been made to express and purify the full length protein for 
characterization; however, these past efforts have not been as fruitful [55]. 
1.8. Research Project 
1.8.1. Background and Objectives 
Attempts have been made in developing an expression system in E. coli to allow 
for the isolation of CeAPN-l. This was performed by constructing a plasmid containing 
the Ceapn-l gene under the control of an isopropyl P-D-l-thiogalactopyranoside (IPTG) 
inducible promoter. Unfortunately, the expressed product detected via immunoblot 
appeared to be smaller (10 kDa) than the expected size. Hence, a possible proteolytic 
process in bacteria may have been hindering the detection of the fulliength prote in [55]. 
Due to the inability to detect the full length CeAPN-l in bacteria and the fact 
that a sufficient yield (for characterization experiments) could not be obtained via C. 
elegans, an expression system was engineered in yeast [86]. This particular eukaryotic 
model has multiple advantages stemming from the fact that it is easy to manipulate and 
grow. Moreover, it should be recognized that a significant benefit arises from the fact 
that a mutant strain void of AP endonuclease, YW778 (tppl 1'1: :METl5 apnl A: :HIS3 
apn2A::KanMX4), was readily available. Through the subsequent transformation ofthis 
strain, one could easily ascertain whether the introduction and expression of Ceapn-l 
can functionally complement in the presence ofDNA damaging agents [86]. 
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It was shown that the yeast plasmid containing the Ceapn-1 gene, pNLS-OAD-
Ceapn-J (recovered from a C. elegans cDNA library), was able to substitute for yApn1 
in the presence of MMS when introduced in the YW778 strain. As a result, a new 
construct was designed in order to equip the expressed product with a OST affinity tag 
for purification purposes [86]. Unfortunately, unlike the previous attempt, the 
introduction of pOST -Ceapn-1 failed to restore MMS resistance to the AP endonuclease 
deficient strain. An identical approach exploiting a OST tagged Ceexo-3 construct 
introduced into YW778 (tppl tl..::METl5 apnll1::HIS3 apn211::KanMX4) (void of AP 
endonuclease activity) did, however, display an ab il it y to complement in the presence of 
MMS. Thus, it was hypothesized, at the time, that the failure of OST -Ceapn-l to restore 
resistance was likely due to the OST tag that may have been hindering the activity 
domain of the protein [86]. It was, however, later discovered (during the course of the 
CUITent project) that the Ceapn-l sequence was more extensive than originally believed 
to be. Updated and better annotated sequences submitted to gene databases revealed that 
Ceapn-1 is composed of an additional 118 amino acids at the N-terminal which was not 
previously accounted for. Upon close inspection, the additional residues have been 
pointed out to being highly rich in basic residues (characteristic of NLS) which may be 
indicative that it may play a role in protein localization [87]. 
As a result, this project set out firstly to develop an effective expression system 
for CeAPN-I, secondly, to isolate a homogeneous fraction of the prote in and, thirdly, 
characterize its precise biological function in an in-vitro setting. The goal in 
characterizing CeAPN-I rests primarily on determining the types of les ions (AP sites, 
3' -blocked ends, oxidized bases) it can process, evaluate its range of activities, assess 
whether additional co-factors are needed for its function and to differentiate it from its 
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counterparts. FourthIy, it was aiso our intention to conduct a domain function analysis, 
through site directed mutagenesis, in order to better understand the characteristics that 
make up CeAPN-1 and specifically, shed light upon sorne significant amine acid 
residues that contribute to its activities. Thus, we confirmed that the introduction of the 
tagged proteins, GST-CeAPN-l-HIS and GST-HIS-CeAPN-l, can respectively rescue 
a strain deficient in AP endonuclease activity while in the presence of DNA damaging 
agents (MMS, Bleomycin, H20 2). Partially purified fractions containing the 
recombinant CeAPN-l protein revealed that the AP endonuclease and 3' diesterase 
components were retained. However, fractions obtained following full purification 
exposed a dramatic decrease in protein activity. Interestingly, it was demonstrated that 
the addition of crude extracts stemming from the YW778 strain (free of AP 
endonuc1ease activity) caused a significant increase in the activity level. Collected data 
has suggested that a potential heat stable factor may be stimulating the activities of the 
Endo IV prote in under study; nonetheless, its true identity has yet to be determined. 
Furthermore, domain function analysis confirmed the significance of the E 143 and E97 
residues in governing the ability of the enzyme to remain functionally active. Thus, the 
variants, E143G and E97G, failed to demonstrate a capacity to substitute for yApnl in 
the presence of DNA damaging agents. The results observed are in accordance with 
data previously obtained involving the study of charged residues contained in one of the 
four conserved Endo IV family domains affecting activity [88] [79]. 
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2. METHOD AND MATERIALS 
2.1. Yeast and Bacterial Strains 
The S. cerevisiae strains utilized in this study were the parent YW465 (MATalpha 
ade21'10 his31'1-200 leu21'1-1 met51'10 trpll'1 ura31'10) and its isogenic mutant derivative, 
YW778 (apnll'1::HIS3 apn21'1::KanMX4 tppll'1::MET15). Both strains were obtained 
previously from Dr. Tom Wilson (University of Michigan) and preserved on YPD agar 
supplemented with adenine 20 ~g/ml. The E. coli strain used in this study was DHI O~ 
which was maintained on LB agar. 
2.2. Plasmid Construction 
Name Sequence (5'-3') 
AACTCCAAGCTTATGCCCAAGAAGAAGCGGAAGGTCTCGAG 
NLS-His-Ceapn-l-Fl CGGCCATCATCATCATCATCATAAAAAAAAATCTCGTGAAAC 
G 
Ceapn-l-Rl TTATCTTTTATCCATATTGTACAT 
vector-NLS-Ceapn-l-F 1 AACTCCAAGCTTATGCCCAAGAAGAAGCGGAAGGTCTCGAG CGGCAAAAAAAAATCTCGTGAAACGGTTGGCGTGGAAG 
TTGATCATTCATCAGTAAAAAAGTTATGCAATTAAACAAGAA 
Ceapn-l-His-vector-Rl TTAATGATGATGATGATGATGTCTTTTATCCATATTGTACATG 
TTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGAGAT 
GST -NLS-Ceapn-l-F CGAAATGCCCAAGAAGAAGCGGAAGGTC 
GST-NLS-Ceapn-l-R TTCAGTATCTACGATTCATAGATCTCTGCAGGTCGACGGATC CCCCGACGTCTTACTTACTTAGCGGCCG 
E143G region2-Fl ATTATTTTAGTTCTCGGGACAATGGCTGGACAAGGG 
E143G region2-Rl CCCTTGTCCAGCCATTGTCCCGAGAACTAAAATAAT 
E97G region I-F 1 CGAATGTCAACGGGCTGGGAAATTAGGAATCACG 
E97G regionl-Rl CGTGATTCCTAATTTCCCAGCCCGTTGACATTCG 
Oligo U GCTGCATGCCTGCAGGTCGAUTCTAGAGGATCCCGGGTACCT 
Oligo G AGGTACCCGGGATCCTCTAGAGTCGACCTGCAGGCATGCAGC 
Table 2-1: Oligonucleotides Utilized in Study 
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pAS3A (pPC86 from Invitrogen C. elegans cDNA library) containing the C. 
elegans apn-l gene was used as a template for PCR (refer to Fig 3-1). The prim ers 
(NLS-His-Ceapn-l-Fl, Ceapn-l-Rl) were designed to allow the insertion of a His tag at 
the flanking end of the gene and, thus, enable the simultaneous removal of the large 
GAD sequence (refer to fig 3-1). The resulting product was purified via electrophoresis 
(l % agarose TAE gel) whereby the corresponding band signal was excised and purified 
via gene c1eaning kit (Amersham Piscataway, NJ). Additional pAS3A plasmid was 
meanwhile digested with Sali and Ncol. The linearized product was recovered through 
electrophoresis. Hence, the band representing the cut plasmid was excised and purified 
as mentioned above. The desired construct, pHis-Ceapnl, was obtained via gap repair 
whereby a wild type strain was co-transformed with the PCR generated His-Ceapn-l 
product and the digested pAS3A plasmid. Resulting transformants were selected on -
Trp agar plates (plasmid carries a Trp marker). 
A second plasmid, pCeapnl-His, characterized by a C-terminal His tag was 
designed by exploiting pHis-Ceapn-1 as a PCR template for the primers, vector-NLS-
Ceapn-l-Fl and Ceapnl-His-vector-Rl to obtain a final product consisting of NLS-
Ceapn-l-His (refer to Fig 3-2). The PCR fragment was purified via conventional 
electrophoresis means (as mentioned above). Concurrently, pAS3A was digested using 
the same steps as described above. pCeapnl-His was obtained in the same fashion as 
pHis-Ceapn-l; thus, involving the co-transformation of the NLS-Ceapn-l-His fragment 
and the cut plasmid in the YW465 strain. Transformants were similarly selected on -
Trp agar plates. 
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The third plasmid, pGST-His-Ceapn-l, which allowed the expression of two 
affinity tags was constructed using the previously obtained pHis-Ceapn-l as the PCR 
template and the primers, GST-NLS-Ceapn-l-F and GST-NLS-Ceapn-l-R, to obtain a 
fragment consisting of GST-NLS-His-Ceapn-l (refer to Fig 3-3). The pTW340 plasmid 
(bearing the gene OGG 1 with a GST tag) was digested (Sma1 and EcoR1 to remove 
OGG 1) in paraIlel, and thereafter, used in the final gap repair step with the PCR 
product. It should be noted that transformants were selected on -Ura plates. 
The final plasmid in question, pGST-Ceapnl-His, was designed in the manner 
as pGST-His-Ceapn-l with one modification; hence, the pCeapn-l-His plasmid was 
exploited as the PCR template (refer to Fig 3-4). Therefore, the plasmid has an N-
terminal GST tag and a C-terminal His tag (refer to Fig 3-4). 
2.3. Isolation of Plasmid DNA and Transformation: 
AIl techniques involving the extraction of plasmid DNA and transformation 
were performed by following the protocols given by Sambrook et al (1989) [89]. 
2.4. Expression System for Recombinant Proteins: 
The respective plasmids (pCeapnl-His, pHis-Ceapnl, pGST-His-Ceapnl and 
pGST-His-Ceapnl) were utilized to transform YW778. Resulting transformants 
stemming from the introduction of pCeapn 1-His, pHis-Ceapn 1 and pGST -His-Ceapn 1, 
GST-His-Ceapnl were selected on -Trp and -Ura plates respectively. The selection 
plates consist of minimal medium agar (lacking the corresponding tryptophan or uracil). 
The transformants were grown in the appropriate liquid minimal media for proliferation. 
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2.5. Gradient Plate Assay: 
Gradient plate analysis was conducted as explained in previous trials [61, 78]. In 
essence, cultures were grown overnight in selective minimal media and thereafter, 
replicated on a plate (YPD media) containing the DNA damaging agent gradient. The 
plate was incubated for 48 hours at 30°C and later photographed. 
2.6. Extraction of Proteins for Expression Analysis: 
Cultures were grown overnight and subsequently, harvested from liquid minimal 
media via centrifugation at 4000 rpm (Sorval RT-7). The supernatant was discarded and 
the ceU pellet was washed twice with water. The resulting pellet was thereafter 
resuspended in buffer A (50 mM Tris-Hel, 50mM NaCI, 10% glycerol) with protease 
inhibitor cocktail (Complete Mini, EDTA-free, Roche Diagnostics GmbH). 
Resuspended ce Us were beated with 425-600 Ilm glass beads (Sigma, St Louis, MO) via 
the utilization of a Mini-Beadbeater (BioSpec Products, Bartlesville, OK) at 4800 rpm 
for 20 seconds. It should be noted that the beadbeating step was repeated 5 times. Cell 
debris was separated through centrifugation which consisted of 5 minutes at 1000 rpm 
at 4° C using a tabletop microcentrifuge (Jouan, lnc. Winchester, V A). Extracts were 
isolated and quantitated via the traditional Bradford method [90]. 
2.7. Extraction of Proteins for Purification: 
Cultures were grown over 3 days in minimal media. Thus, culture was initiated 
in 10 ml of minimal media, sub-cultured the second day in 100 ml of minimal media 
and finaUy added to 900 ml of fresh media. The 1 L culture was allowed to grow 
overnight. Thereafter, ceUs were harvested via centrifugation at 4000 rpm (Sorval RT 7) 
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and the resulting pellet was thoroughly washed three times with water. The cell pellet 
was aliquoted and stored at -800 C. However, for extraction purposes, 10 ml of cell 
pellet was resuspended in an equal volume with buffer A with protease inhibitors and 
bead beated via Maxi-beadbeater (BioSpec Products, Bartlesville, OK). It is important 
to note that the beating container was filled 70% with glass beads. Subsequently, the 
resuspended cells were added to the beads while ensuring no air space was remaining in 
the holder (added buffer A to ensure the container was filled). Cells were incubated in 
ice for 2 minutes and, thereafter, beated for 20 seconds; this process was repeated 20 
times. Resulting extracts were centrifuged at 18 000 rpm for 10 minutes while at 40 C 
(Sorval SS34). Thereupon, the supematant (protein extracts) was collected and stored at 
-20 C. 
2.8. Site Directed Mutagenesis: 
Two site directed mutations were performed by the Quickchange kit (Stratagene, 
La Jolla CA). The substitutions, E143G and E97G, were individually made via PCR 
using the corresponding polyacrylamide purified primers, (E143G region2-F1, E143G 
region2-R1 and E97G region1-FI, E97G region1-R1), and the pGST-His-Ceapn-1 
plasmid as the template. The obtained PCR products were incubated with Dpnl and 
later utilized in the transformation of the bacterial DH10p strain. Transformants were 
selected on LB-Ampicilin plates and the plasmid DNA was later isolated and 
sequenced. Finally, the sequenced plasmids containing the corresponding mutations 
were used to transform YW778. Transformants were isolated on -Ura minimal media 
agar plates. 
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2.9. Protein purification Through Using a His-Affinity (Talon) Column: 
Column resin was equilibrated with 20 volumes of Buffer A. Protein extracts 
were loaded into column and recycled 5 times through gravity. Following binding, resin 
was washed with 5 volumes of buffer A and 15 volumes of buffer B (50 mM Sodium 
Phosphate, 300 mM NaCI) at pH 7. Elution process was achieved by collecting five 200 
III fractions buffer C at pH 7 (Imidazole Elution buffer as given by Clontech resin 
manufacturer) which is composed of 50 mM Sodium phosphate, 300 mM NaCI, 150 
mM Imidazole. Final elution fractions contained 20% glycerol. 
2.10. Purification Using a Glutathione Sepharose Column: 
To achieve purification of GST tagged proteins, collected extracts were diluted 
50% with additional buffer A (containing protease inhibitors) and Triton-XIOO before 
resin binding. The GST tagged proteins were purified using a glutathione-sepharose 
resin (GE-Healthcare) following general instructions specified in manufacturer 
handbook. Briefly, the resin was centrifuged at 500 x g to remove storage solution and 
subsequently washed with lx PBS (140 mM NaCI, 2.7 mM KCI, 10 mM Na2HP04, 1.8 
mM KH2P04) five times. The resin was centrifuged following each wash and 
subsequently incubated at room temperature (in order to resuspend) on a rocker for 5 
minutes. Thereupon, prote in extracts were added to the equilibrated matrix and 
subsequently rotated for 40 minutes (room temperature). Following incubation, extracts 
were spun down (500 x g) and the unbound supernatant was collected and saved at -
20°C. The resin was washed 5 times with lx PBS + 1% Triton on a rotator and 
centrifuged (500 x g) at 4°C. Elution was performed on a column at 4°C. Hence, 5 x 1 
ml fractions were collected following the addition of elution buffer (50 mM Tris-HCI 
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pH 8, 10 mM reduced glutathione). Glycerol was added to each fraction to a final 
concentration of 20%. The eluted fractions were stored at -20°C. 
2.11. SDS PAGE Staining and Western Blot 
Crude prote in extracts and eluted fractions were separated on a SDS PAGE gel 
containing 10% acrylamide,lbisacrylamide through electrophoresis . 
2.11.1 Sypro Staining: 
Obtained gel (post electrophoresis) was fixed in solution D (10% MeOH, 7% 
Acetic acid) for 30 minutes and stained with Sypro-Ruby (Biorad, Hercules CA) for 3 
hours. Thereupon, the gel was destained with solution E (10% MeOH, 7% Acetic acid) 
for 90 minutes while changing solution 3-4 times until appropriate resolution was 
achieved. 
2.11.2 Western Blot: 
Transfer was performed on a nitrocellulose membrane (Amersham, Piscataway, 
NJ). The membrane was incubated overnight with 0.1 % anti-HIS (for single HIS fusion 
protein) (Santa Cruz Biotechnology, Santa Cruz, CA) and 0.05 % anti GST and later 
probed with a secondary antibody (anti-mouse for anti-His, anti-rabbit for anti-GST). 
Resulting image was developed following exposure with chemiluminescence solution 
(Perkin Elmer, Woodbridge, ON). 
2.12. Preparation of AP Endonuclease Substrate: 
The 42mer, oligo U (5'-GCTGCATGCCTGCAGGTCGAUTCTAGAGGA-
TCCCGGGTACCT-3') (3.5 ng) was labelled with [y)2 P]ATP using T4 polynucleotide 
kinase (USB, Cleveland OH) as performed previously [91]. The end labelled 
39 
oligonucleotide obtained following ethanol precipitation was subsequently, annealed to 
a complementary oligonucleotide G (3' -
CGACGTACGGACGTCCAGCTGAGATCTCCTAGGGCCCATGGA-5 ' as 
previously performed [84]. The newly formed double stranded oligo was later treated 
with 25 units of Uracil DNA glycosylase (UDG) in buffer F (30 mM HEPES-KOH, pH 
7.6, 50 mM NaCI, 2 mM EDTA) for 30 minutes at 37°C to form the AP site substrate. 
The reaction was terminated via a 10 minute heat treatment at 65°C [88, 92]. 
2.13. Preparation of 3' Diesterase Substrate: 
The 3' diesterase substrate was prepared as previously described [93]. Briefly, 
the previously obtained oligonucleotide (AP endonuclease substrate) was treated with 
25 units of Endo III at 37°C for 60 minutes. The reaction was terminated via a 10 
minute heat treatment at 65°C [91]. 
2.14. Preparation of YW778 Extracts for Activity Assays: 
Extracts were prepared in the same fashion as described earlier for expression 
analysis. For heat treatment experiments, however, small aliquots of collected extracts 
were heated in 1.5 ml eppendorftubes at 95° C in a water bath for 5 minutes. Extracts 
were thereafter spun down on a tabletop centrifuge (Jouan, Inc. Winchester, VA) at 
1000 rpm whereby the soluble fraction was collected. For dialysis experiments 
(evaluating AP endonuclease activity), the soluble fraction Cl 00 III volume) was 
dialyzed against 500 ml of buffer A (20% glycerol) at 4°C. The last step was repeated 
three times (to exchange buffer): twice following 4 hours and maintained overnight 
during third trial. 
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2.15. Enzyme Assays: 
Reactions were performed using buffer G (50 mM Hepes-KOH at pH 7.6, 50 
mM KCI, 1 mM EDTA, 100 ).lg of BSA) in a final volume of 12.5 ).lL. The substrate 
(1.5 ng) was incubated with 1 ng of prote in (unless otherwise indicated). Reactions were 
terminated with the addition of 5 !JL formamide loading buffer (76% formamide, 10mM 
EDTA, 0.3% bromophenol blue, 0.3% xylene cyanole). Thereafter, the samples were 
heated to 65°C for 5 minutes to separate any proteins which may have remained bound 
to the DNA. Reactions were, subsequently, loaded onto a 10% gel and 17% 
polyacrylamide-Urea gel respectively for the AP endonuclease and 3' -diesterase assays 
respectively. Following 1 hour migration, the gel was transferred to Whatman paper, 
wrapped in plastic and placed on a dryer (Biorad, Hercules CA) for 1-2 hours. 
Thereafter, the dried gel was placed in a cassette (GE Healthcare) with screen for 
overnight exposure. The image was developed via Storm Scanner (GE Healthcare). 
2.16. Homology modeling of CeAPN-1 
The deduced protein sequences of Ceapn-1 was submitted to the Swiss-Model 
server (Automated Comparative Prote in Modeling Server, Version 3.5) [94, 95] for 
comparative protein structure modeling. All homology models were subsequently 
generated based on the template of E. coli endonuclease IV (PDB accession number: 
1QTW and 1QUM; [68]) using Swiss-PdbViewer 3.7 [95, 96]. The electrostatic 
potential and molecular surface of each prote in model was calculated through eF -surf 
server and visualized through PdbViewer (Version 3.0) [97]. 
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3. RESULTS: 
3.1. Plasmid Construction: 
The pPC86 plasmid (refer to method and materials) carrying the C. elegans apn-
1 gene (plasmid re-named pAS3A5) was utilized as a PCR template to amplify the gene 
in question. The primers, v-NLS-His-Ceapn1-F1 and Ceapn1-v-R1 were designed to 
allow the insertion of a His tag between the NLS and the gene and simultaneously 'Ioop 
out' the large GAD sequence (separating the NLS and apn-1 coding sequence) found 
within the plasmid. Thereupon, a resulting fragment composed of NLS-His- Ceapn-1 
was obtained and subsequently co-transformed in YW465 with linearized pAS3A. The 
yeast system allows the fragment to recombine with the digested plasmid via gap repair. 
pAS3A 
pHis-Ceapn-l 
F orward primer 
Ceà'n:I~­p, 
+ Dig,,',d pAS3A 1 aap ilHpai, 
Ceapn,,! 
"'-,-
1 
1 
+-'j>·C"··,'_ ri, eapl17J 
Reverse primer 
Figure 3-1: Construction of Ceapn-l Expression Plasmid with N-
Terminal His Tag 
Ceapn-1 was retrieved from a cDNA library using the primers shown (v-
NLS-His-Ceapn1-F1 and Ceapn1-v-R1) above. The gene was 
subsequently cloned into a construct where it was fused at the N-terminal 
to a His affinity tag (forming pHis-Ceapn-1). 
A second plasmid was designed throughout the course of this project which is 
characterized for the His tag being at the C-terminal end of the gene. In essence, the 
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pHis-Ceapnl plasmid was used as the template for the designed primers v-NLS-Ceapn-
l-and Ceapnl-His-v. These primers would allow the simultaneous 'looping out' of the 
original N-terminal His tag and resulting incorporation of the tag to the C-terminaL 
Forward primer 
pHis-Ceapf'-1 •••• '~ 
+ Dig,,"d plfu-Co",n-l t Oap i1Epair 
pCeapn-l-His_~lt;ti:;:~",:'~~~t~!§,~p,g~;:JI,:~!(\;< 
Reverse primer 
Figure 3-2: Construction of Ceapnl Expression Plasmid with C-
Terminal His Tag 
A second plasmid was construeted using speeifically designed primers (v-
NLS-Ceapn-l-and Ceapnl-His-v) to allow the His affinity tag to be fused 
at the C-terminal of the gene. The plasmid, pHis-Ceapn-l, was used as a 
template for the primers utilized. 
Both plasmids shown above were separately utilized to produee a dual tagged 
construct (composed ofboth His and GST affinity tags). Renee, primers were carefully 
designed to allow utilization against both templates and coneurrently produce the 
constructs pGST-Ris-Ceapn-l and pGST-Ceapn-l-His. 
F orward primer 
pGST-His-Ceapn-l 
-
-,-
\ 
1 
~ 
Reverse primer 
Figure 3-3: Construction of Ceapn-l Expression Plasmid with 
Dual N-Terminal GST and His Tags 
A dual tagged plasmid consisting of GST and His affinity sequences 
were inserted in frame at the N-terminal of the Ceapn-l gene. The 
PCR product was obtained using the primers, GST-NLS-Ceapn-l-F 
and GST-NLS-Ceapn-l-F, and pHis-Ceapn-l plasmid (section 2.1). 
Forward primer 
+ m."redpTW340 1 Gap &paù 
_f;W·i_-·,f:Wl1:$fl!:'if,'i:"!);i~4lL:slit't· . 
pGS'T-Ceapn-l-His 
-,-
1 
1 
~ 
Reverse primer 
Figure 3-4: Construction of Ceapn-l Expression Plasmid with 
dual tagged N-terminal GST and C-terminal His 
A second dual tagged plasmid was concurrently constructed 
consisting of affinity sequences at opposing ends of the Ceapn-l 
gene. Cloning was accomplished using the pCeapn-I-His plasmid 
and the GST-NLS-Ceapn-l-F and GST-NLS-Ceapn-l-F primers. 
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3.2. Cross Species Complementation: 
pHis-Ceapn-l was the first plasmid to be constructed and subsequently 
introduced into AP endonuclease deficient YW778. To assess whether the protein was 
expressed and able to rescue the mutant yeast strain (YW778) from DNA damaging 
agents, a gradient plate assay was performed. The YW778 strain (lacking both Endo IV 
and Exo III components) is hypersensitive to MMS (induces AP sites) and, thus, unable 
to process the created AP sites. Consequently, it grows only a very short distance along 
the increasing gradient composed of the DNA damaging agent. In contrast, a wild type 
strain (YW465), equipped with AP endonuclease activity, is able to resist damage 
induced by MMS and sustains growth along the entire gradient. 
Figure 3-5 shows that the introduction of pHis-Ceapn-l into YW778 rescues the 
mutant phenotype; thus, protecting the strain from MMS induced damage. Interestingly, 
the newly transformed strain, YW778 with pHis-Ceapn-l, maintains the same level of 
growth as the parent strain (YW 465) when exposed to the alkylating agent (MMS). The 
assay confirms that the construct is able to encode a functionally active recombinant 
protein in the yeast expression system. It should be noted that this phenomenon was 
equally revealed with the introduction of the other plasmids made during the course of 
this investigation (pCeapn-I-His, data not shown; pOST -His-Ceapn-l, see Fig 3-27; 
pOST-Ceapn-I-His, data not shown) into YW778. 
Introduced Plasmid 
1 YW778 pCeapn-l-His 
2 YW465 
3 YW778 
4 YW778 Empty vector 
0% 
[MMS] 
Figure 3-5: Cross Species Complementation Analysis 
1 
0.008% 
A gradient plate assay was conducted to observe the ability of Ceapn-l 
to substitute for yAPNJ in yeast. Analysis was perfonned via an 
increasing gradient of MMS, an agent known for causing the fonnation 
of AP sites. As a result, a wild-type strain (Lane 2), equipped with AP 
endonucleases, is shown to grow the full length of the gradient. In 
contrast, a mutant strain (YW778), deficient in AP endonuclease 
activity, is only able to grow a very short distance, as shown in lane 3. 
The introduction of a plasmid allowing the expression of His-Ceapn-l in 
the mutant strain (Lane 1) parallels the growth of the parent strain and 
consequuently, ascertains its ability to substitute for its homologue. 
3.3. Sampling of Adopted Purification Schemes: 
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Multiple purification schemes were attempt~d throughout this project in order to 
produce a fully homogeneous fraction containing the protein of study (CeAPN-l-HIS). 
Figures 3-6, 3-7 & 3-8 show a sampling of the various steps, purification columns 
(Talon/His affinity, DNA affinity, anion exchange) and expression plasmids (described 
above) that were exploited in order to obtain a homogeneous protein fraction; however, 
• 
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only a selected set would be discussed in this report. Hence, the experiments containing 
an asterisk (*) are included in the results section . 
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Figure 3-6: Purification ofHIS-CeAPN-l 
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Figure 3-7: Purification of CeAPN-I-HIS 
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Figure 3-8: Purification of Dual Tagged Protein 48 
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3.4. Purification Attem pts of CeAPN -1 Fusion Protein 
Preliminary attempts adopted a single step approach, thus, exploiting a His 
affinity column to isolate the His tagged recombinant protein. The failure to capture a 
significant and fully pure fraction had forced the utilization of additional techniques to 
complement the affinity resin and achieve full purification. Sorne of these methods 
comprised the utilization of an ammonium sulfate treatment to progressively fractionate 
extracts, heat treatment to isolate thermo stable components, anion exchange matrices in 
order to separate proteins on the basis of charge and additional affinity techniques (i.e. 
DNA binding affinity). The design of the construct and the nature of the resulting 
folding of the expressed product were as weIl scrutinized. Moreover, the choice and 
number of affinity tags (single versus dual tagged) were also parameters that were 
pondered and experimented with to increase efficiency. 
It should be noted that not aIl of the purification schemes that were carried out 
are illustrated in this thesis. The results section, in fact, only highlights the single 
purification step approach that was performed in the isolation of HIS-CeAPN -1, 
CeAPN-1-HIS and the dual tagged recombinant prote in, GST-HIS-CeAPN-l. 
3.4.1. Gravit y-Flow Column purification of the HIS-CeAPN-1 Recombinant Protein 
Figures 3-9A and 3-9B reveal the data obtained following a column purification 
attempt of HIS-CeAPN-l. It should be noted that the prote in extracts were passed 
through the His affinity column via gravity. It is believed that this technique would 
increase binding efficiency by allowing more time for the appropriate proteins to 
interact with the affinity resin without forced agitation which may disrupt the desired 
association. 
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Figure 3-9A represents an AP assay conducted to monitor protein activity 
throughout the different steps of the purification scheme. Thus, a 42 bp 32p labeled 
oligonuc1eotide containing an AP site at the 21 st bp of the strand was utilized as 
substrate for AP endonuc1ease. In the presence of enzymatic activity, the 42mer (upper 
band) is c1eaved 5' to the AP site to produce a 20mer (lower band). As a result, lane 4 
shows that the addition of crude extracts generates substrate turnover; thus, confirming 
the presence of active AP endonuc1ease (HIS-CeAPN-1) in the sample. Similarly, of the 
7 subsequent eluted fractions, it is observed that only fraction 2 (F2) in lane 4 shows 
significant substrate turnover; suggesting the definite presence ofHIS-CeAPN-l. Figure 
3-9B demonstrates the western blot, probing with 0.1 % anti His antibody, that was 
performed to analyze the active fraction, F2 (500 ng), collected from column 
purification. Thus, lane 1 (corresponding to elution F2) reveals the presence of multiple 
bands which may be likely indicative of contaminating proteins in the eluted fraction. 
The inability to detect the recombinant prote in via the anti-His antibody in the crude 
extracts could be due to the fact that an excessive concentration of protein (0.5 mg) was 
loaded. In fact, this phenomenon is also observed in Figure 3-15C whereby at very 
elevated leveJs, protein detection becomes Jess efficient in crude extracts due to over-
saturation. Figures 3-9B and 3-9C reveals that the band signal representing HIS-
CeAPN-l (lane 1) is not the predominant species of intensity in the purified sample. 
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Figure 3-9: Evaluation of single step His Affinity (Talon) column 
purification 
A) 42 bp oligonuc1eotide substrate U21 ·G was incubated at 37°C for 30 
minutes with collected elution fractions (lanes 3-7) from the His affinity 
Talon column. Substrate turnover was eva1uated with a phosphorimager 
following migration on a 10% polyacrylamide/urea gel. 1.5 ng of 
substrate was utilized for each reaction. Lane 1, substrate alone; lane 2, 
substrate with 5 /lg crude extract (pre-column loaded); lanes 3-7, 
collected elution fractions (fractions 1-5). 2 /lI of each fraction (200 /ll) 
was added into each reaction. B & C) The purity of the elution fraction 
F2 (demonstrating activity) was ascertained via western blot analysis 
using 0.1 % anti-His (B) and sypro staining (C). Lane 1 (500 ng), F2; 
lane 2, crude extract (50 /lg) for both western blot and sypro staining. 
Lane 1 demonstrates that the fraction lacks purity as indicated by the 
presence of the contaminating band signaIs. Figure 3-9B shows that 
HIS-CeAPN -1 is found in the investigated fraction, as indicated by the 
arrow. Although active, F2 only shows a very small yield. AIso, the 
recombinant HIS-CeAPN -1 protein is unable to be detected from the 
crude extracts due to the elevated concentration of proteins in the lane, 
as similarly seen in Fig 3-15C-Iane 4. Figure 3-9C (sypro staining) fails 
to clearly distinguish the presence of HIS-CeAPN-l. 
3.4.2. Evaluation of Detected Proteins Following Purification 
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Repeated efforts in isolating a homogeneous protein sample have been mildly 
successful; hence, as opposed to a fully purified fraction, a partially purified but active 
fraction containing CeAPN-1 was obtained. The bands observed via sypro staining may 
indeed be the result of non-specifie bands. However, it is plausible that CeAPN-l may 
be interacting very tightly with other components in the extracts and subsequently 
making the task of obtaining a fully pure protein more challenging. The additional 
bands observed on the corresponding stained SDS PAGE gel following His affinity 
purification could stem also from a form of protein modification affecting CeAPN-1. 
To assess whether the bands commonly observed following elution from the 
Talon column are in fact, representative of interacting proteins, modifications of 
CeAPN-1 or simply non specifie, a parallel purification (using Talon resin) was 
performed. Hence, this was performed using extracts from the original mutant 
background (YW778) and YW778 expressing HIS-CeAPN-1. 
Figure 3-10 reveals a western blot whereby the corresponding eluted fractions 
stemming from the two sets of extracts (YW778 and YW778/pHis-Ceapn-1) are probed 
with anti-His. Hence, lanes 1-2 represent an increasing concentration of F2 from the 
YW778 column while lanes 3-6 show an increasing concentration of F2 stemming from 
the YW778/pHis-Ceapn-1 column. It is clear that most of the bands can be accounted as 
non-specifie. The protein of interest is represented at 34 kDa in lanes 5-6. The 
uppermost band found across lanes 5-6 can be suggested to be the result of a possible 
interacting component with CeAPN-l. The remaining bands of strong intensity, 
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especially that found at 62 kDa, are thought to be non-specifie, the result of 
contaminating proteins. 
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Figure 3-10: Purification Comparison Using Extracts from YW778 
and YW778 Expressing HIS-CeAPN-1 via Western Blot 
Extracts stemming from both strains were loaded onto individual His 
affinity (Talon) columns and purified in parallel. The 2nd elution fraction 
from each respective purification was isolated and evaluated via western 
blot. Lanes 1-2, increasing concentration of F2/ empty strain (YW778), 
lanes 3-6, increasing concentration ofF2/ YW778 strain expressing HIS-
CeAPN-I. 
3.4.3. NewNLS-Ceapn-l-His Construct 
The inability to purify the HIS-CeAPN-l recombinant protein had forced us to 
reconsider strategies beyond general purification schemes. In essence, simple and multi-
step purification approaches failed to yield a pure fraction. The problem may stem from 
the Talon affinity beads themselves and a possible failure of the proteins to securely 
bind to the matrix. It may be suggested that the manner in which the recombinant 
protein was folded may have interfered with binding. Hence, it should be remembered 
that the His tag is found at the N-terminal end between the nuclear localization signal 
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and the gene. Thus, the NLS motif or other structural features of the protein may be 
impeding access to the His tag and subsequently preventing any strong association with 
the affinity beads. Previous constructs utilized to express and purify recombinant forms 
of y Apnl consisted of a tag on the opposite end of the bipartite nuclear localization 
signal. Interestingly, the purification of the yApnl recombinant prote in was not a large 
hurdle as it was observed with the corresponding CeAPN-1 polypeptide. Consequently, 
a second construct was designed in a fashion that the His tag was moved to the C-
terminal of the gene while maintaining the NLS at the N-terminal. 
3.4.4. Single Step Purification Approach 
Protein extracts expressing CeAPN -1-HIS were loaded onto a His affinity Talon 
column in a single step manner without prior manipulation (i.e. no fractionation and 
anion exchange column). Washing and elution steps of the column were performed by 
standard conditions as suggested by the resin manufacturer. The resulting western blot 
(figure 3-11A) demonstrates that the antibody is fairly specifie and the protein of study 
is weIl detected. A coomassie stained SDS-PAGE gel (figure 3-11B) showing the true 
purity of the elution F -2, however, does indicate the presence of multiple bands. 
Evidently, the coomassie reveals that the fraction in question is far from being 
homogeneous. Despite the isolation of an impure fraction, an AP assay (3-11 C) 
indicates that the partially purified elution is, indeed, capable in processing AP sites. In 
fact, the AP site carrying 42mer (1.5 ng) is shown to be weIl converted to the desired 
20mer in the presence of F2. 
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Fig 3-11: Talon Column Purification ofCeAPN-l-HIS Protein 
A one step purification scheme (utilizing Talon resin) was performed, in 
order, to obtain a homogeneous fraction composed of CeAPN-l-HIS. 
Thus, a western blot (A) and coomasie stain (B) were completed to 
monitor its effectiveness. A) lane 1, 10 ~g protein extracts used for 
subsequent purification; lane 2, flow through obtained following binding 
with resin; lane 3, 500 ng fraction 2 (F2) collected during final elution 
from beads. B) lane 1, 1 0 ~g crude extracts used for subsequent 
purification; lane 3, 500 ng fraction 2 (F2). An AP endonuclease activity 
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assay (C) was performed (as shown in figure 3-9A) to confirm the 
presence of CeAPN-1 in the collected fraction and assess its enzymatic 
capacity. The upper band represents the 42bp oligonucleotide substrate 
(carrying an AP site), while the presence of a bottom band is 
representative of processed substrate (20mer product). (C) Lane 1, 1.5 
ng substrate alone; lane 2, 5 Ilg crude extract before loading onto beads 
with substrate (1.5 ng); lane 3, 2 III of collected elution fractions (200 III 
each, FI-F5) with 1.5 ng substrate. 
3.5. Characterization ofPartially Purified Extracts Containing CeAPN-I-HIS 
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Although a homogeneous fraction consisting solely of CeAPN-1-HIS had yet to 
, 
be obtained, partially purified extracts were utilized for preliminary kinetics analysis 
and functional studies. Thereupon, an active fraction (F2) obtained following its 
isolation from the Talon column was utilized to perform this initial investigation (as 
seen in figures 3-12A-B). 
3.5.1. Protein Concentration Dependence of AP Site Processing 
Figures 3-12A & 3-12B represent the AP assay and its corresponding graphical 
depiction. The figures demonstrate that substrate conversion occurs fairly quickly while 
increasing enzyme concentration which is, in tum, followed by a plateau in product 
formation. It appears that a significant amount of the substrate (almost 80%) remains 
unprocessed despite increasing the concentration of AP endonuclease. Hence, it is 
possible that the unconverted substrate may be a specific form or species that is unable 
to be processed by the enzyme in question. In fact, one can suggest that a significant 
concentration of the substrate was not optimally processed by the UDG enzyme, which 
is normally utilized to produce the AP site and prime the substrate for AP endonuclease. 
57 
AIso, another likely possibility to explain the failure to achieve complete substrate 
turnover may be linked to the fact that a particular component, yet unknown, may be 
limiting. 
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Figure 3-12: Protein Concentration Dependence of AP Site 
Processing 
AP endonuclease assay (A) was conducted to evaluate the enzyme 
concentration dependence of AP site processing. A) Lane 1, 1.5 ng 
substrate alone; lanes 2-5, substrate (1.5 ng) with an increasing 
concentration of CeAPN-I-HIS (partially purified). B) Product 
formation obtained as a function of protein amount is depicted using the 
Imagequant pro gram. 
3.5.2. Time Dependence of AP Site Processing 
Figure 3-13A shows the AP assay performed to analyze the effect oftime on AP 
site processing. A graphical representation of the corresponding assay is depicted in 
figure 3-13B. It is evident that with increasing time (while maintaining the 
concentration of 42mer and enzyme at a fixed level), the substrate turnover increases 
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steadily in reaction and plateaus following 10 minutes. A similar phenomenon is 
observed, as in the concentration dependence experiments (figure 3-12), whereby full 
conversion of the substrate is not achieved. Hence, this may stem from the quality of the 
substrate accessible to the enzyme in question or the possibility that another factor may 
be limiting. 
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Figure 3-13: Time Dependence of AP Site Processing 
AP endonuclease assay (A) was conducted to evaluate the dependence 
of time on AP site processing. A) Lanes 1-9, 1.5 ng of substrate with 
fixed amount (5 ng) of CeAPN-I-HIS (partially purified) while 
increasing time of reaction (0 min to 40min). B) Product formation 
obtained as a function of time is depicted using the Imagequant 
software. 
3.5.3. Concentration Dependence in the Processing of 3'a,p Unsaturated Aldehyde 
Substrate (3'-Blocked Ends): 
AP endonucleases have classically been shown to be bifunctional; thus, in 
addition to its AP endonuclease component, they have a weIl established 3' -diesterase 
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activity, which enables the processing of 3' blocked ends. Figure 3-14 reveals the 3' 
diesterase assay that was performed to anal yze the bifunctionality, if any, of CeAPN -1-
HIS. The 3'a,~ unsaturated aldehyde substrate (3' blocked end) is obtained by 
incubating the labeled 42mer, already treated with the enzyme UDG, with Endo III (AP 
lyase) which forms the desired 3' blocked end. 
The assay confirms through in-vitro means that CeAPN-1, akin to its 
counterparts of the Endo IV family, is composed of a 3' diesterase component. The 
3'diesterase activity is revealed by the subtle shift caused by the turnover of 3'a,~ 
unsaturated aldehyde group to the 3'OH group. 
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Figure 3-14: Concentration Dependence of 3'a,~ Unsaturated 
Aldehyde 
3' -diesterase assay was conducted to evaluate the dependence of enzyme 
concentration upon the processing 3' a,~ unsaturated aldehyde. Lanes l, 
1.5 ng substrate bearing the 3' a,~ unsaturated aldehyde group following 
Endo III treatment, lane 2-4, substrate with an increasing concentration 
of the partially purified fraction containing CeAPN-l-HIS (0.05,0.5,5.0 
ng). 
3.6. Complete Purification of the CeAPN-l Recombinant Protein 
3.6.1. GST-His-Ceapn-l Construct 
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Successive experiments have showed that the complete purification of the His 
tagged protein requires a complex approach. Two constant hurdles have been 
encountered: the inability of the prote in to be strongly expressed and secondly, the 
inability of the recombinant protein to tightly bind to the affinity matrix. In the hopes to 
simplify the purification scheme and optimize full protein isolation, a second tag was 
fused to the Ceapn-I-His construct. A similar GST tag system was fused to yAPNl to 
perform subsequent characterization [79, 88]. Nonetheless, the utilization of a GST tag 
was initially avoided for this particular project because of previous experiments 
demonstrating that a GST tagged CeAPN-l recombinant protein was not active. It was 
believed that GST, being a much larger tag, may interfere with the integrity of the 
enzyme active site. However, it was only later recognized that the presence of the NLS 
(not included previously) may have the ability to preserve enzyme activity even with a 
bulkier tag. It should be noted that an additional modification was also performed in 
order to alleviate the weak expression of CeAPN-l; thus, the ADH constitutive 
promoter was substituted with a P cup copper inducible promoter. This latter promoter 
had been successfully used in the expression of CeEXQ-3 in yeast [85]. Although the 
ADH promoter is known to be fairly strong, it failed to strongly express CeAPN-I In 
yeast. 
3.6.2. Purification of GST Tagged Protein 
The GST-tagged recombinant protein was purified via a glutathione sepharose 
resin column. In essence, crude extracts were applied to the matrix in question, washed 
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with the appropriate conditions and thereafter, the elution fractions were collected 
following the addition of reduced glutathione. 
The resulting 5 elution fractions are represented on a sypro stained gel (figure 3-
l5A). It is evident that contrary to previous attempts at purification, only a single band 
is observed in lanes 1 and 2 (figure 3-15A) and, moreover, one that coincides with the 
expected size of the recombinant prote in (61 kDa). A silver stained gel was also 
performed (fig 3-15B) where an increasing amount (2, 10, 35 ng) of the isolated fraction 
is represented. The silver stain, being more sensitive than the sypro-stain, may reveal, if 
any, the presence of non-specific components that were not revealed in the latter. 
However, in this particular trial, the isolated fraction appears to be very pure. The 
presence of the protein in the corresponding fraction is confirmed via western blot 
(figure 3-15C) where an increasing concentration of crude extracts (5, 80, 150, 200, 250 
Ilg) and pure protein (l, 5, 20, 35 ng) are individually represented and probed with anti-
His (l: 1 000). The antibody does not appear to detect any fragmented nor non-specific 
proteins in the eluted fraction. 
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Figure 3-15: Analysis of Eluted Fractions from Glutathione 
Sepharose Resin 
Extracts were loaded onto a glutathione sepharose column. Subsequent 
elution fractions were collected following the application of 10 mM 
glutathione. Panel A demonstrates the sypro· stained gel conducted to 
evaluate equal volume (35 ~l) of the individual fractions, F I-F6 (tanes 
1-6) isolated from the resin. Panel B reveals a silver stained gel loaded 
with an increasing amount (l0, 25, 50 ng) of the most concentrated 
fraction (FI) obtained from the elution profile (lanes 1-3). Panel C 
shows a western blot analysis comparing the increasing concentration of 
crude extracts (50, 100, 150, 200 ~g) (lanesl-5) and the most 
concentrated eluted fraction, FI (10,20,80, 120 ng) (lanes 6-8). 
3.7. AP Endonuclease Activity Assay of GST Recombinant Protein 
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Although purified, the corresp?I?-ding AP assay failed to show that the purified 
protein sustained significant activity. The purified C. elegans recombinant protein 
appears to differ in this particular aspect to its c:l1aracterized homologues, ApnI and 
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endo IV, in S. cerevisiae and E. coli [55]. Figure 3-16 shows the collected data from 
the exposed polyacrylamide-urea gel where the activity reactions were loaded. Thus, it 
is demonstrated that the purified protein is indeed unable to process the substrate. 
Although, a faint band coinciding with the desired 20mer (demonstrating cleaved 
42mer) is slightly visible, its intensity remains weak in comparison to what is observed 
in the presence of crude extract (prior to purification) and purified endo IV. The 
inactivity of the purified protein is not believed'to 'stem from a construct defect. Thus, 
the crude extracts, used for subsequent purification, demonstrate to have strong activity. 
One can suggest that the activity was lost during the actual purification process . 
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Figure 3-16: AP Activity Analysis of Purified Protein 
Activity of purified fraction (FI) was evaluated against 1.5 ng of the 
U21 ·0 substrate (42 bp oligonucleotide containing AP site). Lane 1, 
substrate alone; lane 2, substrate incubated with 1 ng of purified fraction 
(FI); lane 3, substrate incubated with 1 ng of bacterial endo IV; Lane 4, 
substrate with 2 Ilg crude extracts used for subsequent column 
purification. 
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3.8. Addition of YW778 Protein Extracts Stimulate CeAPN-1 Activity 
Due to the fact that the crude extracts have shown to retain activity in contrast to 
the fully purified fraction, it was hypothesized that another factor may be involved in 
the stimulation of GST-HIS-CeAPN-1. Thereupon, extracts from the YW778 strain 
were prepared and added in reaction with GST-HIS-CeAPN-l and substrate. Hence, it 
is observed (figure 3-17, lanes 1-4) that the addition of ex tracts does, indeed, appear to 
dramatically rescue protein activity. This particular phenomenon appears to be 
dependent on the concentration of extract added in reaction; thus, lanes 1-4 show a 
steady increase in substrate turnover and a subsequent plateau. 
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Figure 3-17: Addition of YW778 (apnlt1, apn2t1) Protein Extracts 
S!imulate CeAPN -1 Activity 
Detection of AP activity of purified GST-HIS-CeAPN-l fraction (1 ng) 
was monitored in the presence of an increasing concentration (1-1000 
ng) of YYW778 crude extract (lanes 1-4). Lane 5, 1.5 ng substrate 
alone, lane 6, 1.5 ng of substrate with purified protein, lane 7-8, 
substrate (1.5 ng) with increasing concentration (10 ng, 1000 ng) of the 
YW778 AP endonuclease deficient extract. 1 ng of purified endo IV 
(with substrate) was included in lane 9 as a positive control. 
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Methodology 
It has been tentatively shown that the addition of ex tracts appears to stimulate 
the activity of the CeAPN-l recombinant prote in. In order to better understand the 
underlying component causing this phenomenon, the extracts were pre-treated as shown 
in the figure below: 
YIN 778 (apnlL! apn2L!) Ce11 
culture 
l 
1. Prote in 
extracts 
l 
2. Heated Il Boil 
l 
Spin at 10 000 rpm 
r 
3. Collecting supernatant 
(soluble fraction) 
l 
4. DIALYSIS 
Figure 3-18: Treatment of Protein Extracts 
Protein extracts from the AP endonuclease deficient yeast strain 
(YW778) were treated in a series of steps. Extracts collected following 
each of the numbered steps were added individually into reaction with 
purified GST-HIS-CeAPN-l as weIl as substrate and subsequently 
evaluated for enzyme activity (AP endonuclease). 
The heat denaturation step was included to inactivate the proteins found in the 
extracts. The absence of activity observed following the addition of heated ex tracts 
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would suggest an involvement of proteins in the stimulation of the Endo IV member. 
The dialysis step, on the other hand, was conducted in the event that the previous heat 
treatment would not affect activity stimulation. Hence, this particular step would be 
effective in removing aIl metal factors in the extracts (components under 5000 Da). 
Thereupon, the absence of activity following the addition of dialyzed extracts would be 
indicative that a rnetal ion rnay be involved in the function of GST -HIS-CeAPN-I. 
3.8.1. Addition of Heated Extracts 
In order to perform a prelirninary analysis to 'narrow down' the identity of the 
component, if any, causing the stimulation of activity, protein extracts were heated to 
95° C for 5 minutes and added to reaction with purified protein and substrate. The heat 
treatment is exploited to denature proteins in extracts and render thern inactive; 
consequently, if would allow one to deduce whether the component responsible for the 
stimulation is a metal factor or a protein. 
Figure 3-19 shows the corresponding data obtained following the AP assay. It is 
observed that despite strongly heating the extracts, substrate turnover (illustrated by the 
formation of 20mer product) is preserved. Substrate turnover is not observed when 
heated extracts are assayed in the absence of CeAPN-l (Lanes 2-3). This particular 
reaction serves as a negative control demonstrating the extracts alone do not contain AP 
endonuclease activity. One should further note, as shown earlier, that the CeAPN-l 
al one produces very little, if not at aIl, of the processed 20mer. 
.§ 778 ext 
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Figure 3- 19: Addition of Heated Protein Extracts 
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AP endonuclease deficient (YW778) extracts were pre-heated for 5 
minutes at 95° C and thereafter, added in an increasing concentration in 
reaction with purified protein and substrate (maintained concentration). 
Lane 1, substrate alone (1.5 ng); lanes 2-5, 1.5 ng substrate with 
increasing concentration of both heated and non heated AP endonuclease 
deficient extracts respectively (10 ng, 1000 ng); lane 6, 1.5 ng substrate 
with 1 ng of purified endo IV; lane 7, substrate with 4 !-tg crude extracts 
utilized in the purification of GST-HIS-CeAPN-1; lanes 8-11, constant 
level of substrate (1.5 ng) and purified GST-HIS-CeAPN-1 incubated 
with an increasing concentration of heated YW778 extracts. 
3.8.2. Addition of Specifie Metal Factors 
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Due to the fact that heated extracts were able to stimulate CeAPN-1 activity, it 
was assumed that a protein would likely not be involved. In fact, a metal factor was 
thought to be the more likely candidate since it remains unaffected by the heat 
treatment. Thereupon, several metal factors were individually added to reaction with 
purified recombinantprotein in order to assess for activity stimulation. The metal 
factors evaluated included Zn2+, C02+ and Mn2+ as shown in figure 3-20. Metal ions 
(transition metals) often, play an important role in stabilizing protein structure [98]. 
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However, none of the factors suggest to confer any activity stimulation. In essence, the 
42mer substrate remains unchanged despite the addition of metal factors. Additional 
factors, including Mg2+, Ni2+ and Ca2+ have been tested in the past with partially 
purified extracts but similarly did not reveal any activity stimulation (data not shown). 
G-H-CeAPN-1 + meta1 ions 
o 0 
ci 'ci ' 
2 3 4 5 6 7 8 9 ID II 12 
Figure 3-20: Evaluation of Metal Ion Dependence ofG-H-CeAPN-l 
Activity of G-H-CeAPN-l (GST-HIS-CeAPN-l) was evaluated in the 
presence of various divalent metal ions, which included Zn2+, C02+, and 
Mn2+. Thus, individual metal ions were added as 2 specifie 
concentrations (0.1 mM and 1.0 mM) while maintaining the level of 
purified protein and substrate. Lane 1, 1.5 ng substrate alone (constant in 
ail other reactions involving substrate); lane 2, 1 ng of purified prote in 
with substrate, lane 3, substrate incubated with 1 ng purified protein and 
100 ng of heated AP endonuclease deficient (YW778) extracts; Janes 4-
5, substrate with 100 ng heated and non-heated YW778 extracts 
' .. 
respectively; lane 6, substrate with 1 ng of purified endo IV; lanes 6-11, 
substrate incubated with 1 ng of purified protein and an increasing 
concentration (0.1 mM and 1 mM) of the respective individual metal 
ions (Zn2+, C02+, and Mn2+). 
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3.8.3. Addition of Dialyzed Extraets 
In order to further assess the nature of the observed phenomenon, extraets were 
thoroughly dialyzed (tubing pore size eonsisted of a moleeular weight eut off of 5000 
Da) following heat treatment and subsequently, applied in reaction with pure protein 
and substrate. The dialysis was performed to allowmetals and other small components 
(under 5000 Da) to be removed from the extraets. As a result, despite heating and 
dialysis steps, fig 3-21 reveals that the extracts still stimulate the aetivity of GST -H1S-
CeAPN-L 
YW778 heated ext 
dialyzed (ng): 0 10 100 1000 
G-H-CeAPN-l (ng): 
2 3 4 5 6 7 8 9 10 
Figure 3-21: Addition of Dialyzed Extracts 
YW778 extracts were dialyzed (following heat treatment) in order to 
fully remove any metal components that may be found in the sample. 
These treated extracts were thereafter, incubated in an increasing 
concentration with the purified recombinant protein G-H -CeAPN-l 
(GST-HIS-CeAPN-1) and 1.5 ng of U21 ·G substrate (42 bp 
oligonuc1eotide). Lane 1, substrate alone in reaction; lane 2, substrate 
incubated with 1 ng GST -HIS-CeAPN-1; lane 3, substrate with purified 
protein (lng) and heated 100 ng of YW778 extracts, lane 4-5, substrate 
with 100 ng of heated and non-heated YW778 extracts respectively; lane 
6, substrate with 1 ng of endo IV protein; lanes 7-10, substrate with 
purified recombinant protein and an increasing concentration of dialyzed 
YW778 extracts. 
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3.8.4. Summary ofObserved Results: 
YW 778 (apl'llL! apl'l2L1) Cell Effect on CeAPN-l Activity 
culture 
l 
1. 
Prote in 
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4. DIALYSIS + 
Figure 3-22: Summary of Observed ResuUs Following the Addition 
of YW778 Protein Extracts 
AP endonuclease activity associated with GST -HIS-CeAPN-l was 
manifested following the addition of AP endonuclease deficient extracts. 
This activity was maintained despite the various treatments issued to the 
extracts (i.e. heating and dialysis) 
3.9. Domain Function Analysis 
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It is known that 5 conserved domains exist within the Endo IV family. Four of 
the five domains have been correlated to govern protein activity; thus, key residues in 
these segments have been implicated in DNA binding and the coordination of zinc 
atoms within the active site. 
Active site c onsisting 0 f Znl+ 
c1uster 
Figure 3-23: Model of CeAPN-l Based on Known en do IV Structure 
The Swiss Model Server program (v3.5) was utilized to develop a model 
of the CeAPN-1 protein structure. The model is inspired by the known 
and weIl characterized structure of the bacterial homologue, endo IV. 
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Using the obtained CeAPN-1 model structure (refer to Method and Materials 
2.16), one can visualize and extrapolate the predicament awaiting the CeAPN-l protein 
by changing key amino acid residues. Thus, 2 sites have been initially chosen to 
perform site directed mutagenesis (shown in fig 3-24): 
(1) E97G - found in the first domain and makes up a segment of acidic residues 
that may be important in contributing to protein stability. 
(2) E143G - found in the second domain and believed to be key in coordinating 
Z 2+ n . 
Figure 3-24: Chosen Sites for Mutagenesis 
Through the utilization of an alignment of Endo IV family members, 
two sites have been chosen for site directed mutagenesis to enable 
subsequent domain function analysis. Rence, these inc1ude, E143G and 
E97G. 
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It is observed that E143 is embedded deep inside the protein and likely involved 
in playing a significant role in catalytic activity (Fig 3-24 and 3-25). E97, in contrast, is 
found on the· outer shell of the protein structure and its substitution with glycine is 
believed to affect protein stability. In fact, Fig 3-25 shows that E97 is found within a 
rich c1uster of acidic residues which is represented by the red colour tone. In 
consequence, the glycine substitution appears to disperse the rich acidic c1uster and 
subsequently, believed to negatively affect the function of the enzyme (fig 3-25). 
B 
CeAPN-l (wt) CeAPN-1-97 CeAPN-1-143 
.(j.' 
CeAPN-l (wt) CeAPN-l97 CeAPN-1-143 
Figure 3-25: Visualization of Variant Proteins 
Utilization of the Swiss Model server enables visualization of the variant 
proteins. E97 is shown to be on the outer shell of the protein. 
Interestingly, the E97G mutation is shown to cause a dispersal of the 
acidic cluster of amino acids (represented in red). E143, in contrast, is 
found in an interior groove of the protein associated with the active site. 
Consequently, mutation of this particular site (E143G) was believed to 
have negative consequences on the activity of the protein. 
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3.9.1. Expression of Variant Proteins Following Copper Induction in the YW778 
Background 
Yeast strains expressing the variant proteins were induced with copper to allow 
for optimal expression. Thereafter, the cultures were pelleted, thoroughly washed and 
finally evaluated via western blot (Fig 3-26). Figure 3-26 demonstrates that the E97G 
fails to be stably expressed (lane 8). However, there is an accumulating band signal at 
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50 kDa which may be a sign of prote in degradation. In contrast, El43G does, in fact, 
demonstrate to be stably expressed without an excessive accumulation of degradation. 
Native E143G E97G Timeof 
incubation 
+ o 30 o 30 o 30 - (min) 
<;:=1 E>i> protoin (61Kd) 
2 3 4 5 6 1 8 
Figure 3-26: Protein Expression Following Copper Induction 
Comparison of expression levels following the introduction of the 
mutant constructs in yeast. Genes in question are under the control of a 
copper inducible promoter. To optimize expression, cells were incubated 
with a specific concentration of copper (1 mM) for 30 minutes. 
Following incubation, reactions were halted and the ceUs were pelleted 
and subsequently lysed to form prote in extracts. Subsequent 35 Ilg 
samples were probed with anti-HIS to detect expression. Lane 1, 
positive control (extracts expressing previously used GST-HIS-CeAPN-
1); lane 2, negative control (extracts stemming from parent strain), lanes 
3-8, extracts collected following the introduction of the native construct 
and the respective site directed mutants (E143G and E97G) with copper 
induction (0 min and 30 min). 
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3.9.2. Gradient Plate Analysis of Variant and Native Proteins: 
The corresponding strains expressing the variant proteins were thereafter tested, 
via cross species complementation analysis, in order to establish whether the residue 
substitutions have an impact on the ability to process damaged DNA. This was achieved 
by allowing the strains to grow along increasing gradients composed of MMS, H20 2 
and Bleomycin respectively. Thus, as highlighted earlier, MMS was used due to its 
alkylating properties and subsequent indirect role in forrning AP sites. H20 2 was 
included because it causes strand breaks with 3' -blocked ends. Lastly, Bleomycin was 
also exploited due to its strong oxidant capacities to produce single strand breaks 
forming blocked ends (i.e. 3' -phosphate and 3' phosphoglycolate termini), double 
strand breaks and AP sites [71, 72]. Hence, Fig 3-27 shows the wild-type strain YW465, 
containing normal AP endonuclease activity, is able to grow the fulliength of the MMS 
gradient. The mutant YW778 strain lacking AP endonuclease activity (both Endo IV 
and Exo III components), in contrast, is unable to process the created AP sites and 
therefore, fails to grow a significant length on the plate. Strains transformed with both 
site directed mutants, Ceapn-l (E143G) and Ceapn-l (E97G), are equally unable to 
circumvent the increasing MMS gradient and fail to restore parental resistance. Thus, 
the gradient test confirms that the variant E143G, although expressed (unlike E97G), 
carries a significant defect which renders it unable to complement for yeast Apnl and is 
functionally inactive. However, as shown in Fig 3-5, the native form of the protein 
demonstrates that it is able to rescue the mutant strain (lacking yApnl and yApn2). 
This general phenomenon is further evident on both oxidant gradients, H20 2 and 
Bleomycin, as shown in Fig 3-28. As expected, the strain expressing the native 
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recombinant CeAPN-1 is able to restore parental resistance to the DNA damaging 
agents in question. The mutant strains, however, sustain a level of growth which is 
inferior to that of the parental strain. 
Host Strain lntroduced Plasmid 
TW465 
YW778 
YW778 pTW34 0 
YW778 pGST-His-Ceapn-l 
YW778 pE97G 
YW778 pE97G 
0% -~ 0.008% 
(MMS) 
Figure 3-27: Cross Species Complementation Analysis Using MMS 
An increasing gradient ofMMS (with fixed 0.5 mM copper) was utilized 
to assess strain sensitivity following introduction of the native and site 
directed mutant constructs. Lane 1, wild type strain, containing AP 
endonuclease activities is able to grow the full length of the gradient. 
However, the AP endonuclease deficient strain (YW778) grows a very 
minimal distance (lane 2). Lane 3, similarly demonstrates minimal 
growth when the 778 strain is introduced with pTW340 which bears 
OGGI (same backbone as pCeapn-l constructs). Lane 4 reveals parallel 
growth to that of the wild type as Ceapnl is introduced into the mutant 
strain. Lanes 5-6, the respective introduction of the mutants is unable to 
demonstrate cross species complementation. 
Host Strain Introduced Plasmid 
YW465 
YW778 
YW778 pTW340 
YW778 pGST-His-Ceapn-
YW778 pE143G 
yvn78 pE97G 
[Bleomycin] 
Figure 3-28: Gradient Plate Analysis Using H20 2 and Bleomycin 
Sensitivity was monitored similarly to as shown in fig 3-27 but on 
increasing gradients composed of H20 2 (4.0 mM) and Bleomycin (200 
jlg). The AP endonuclease deficient strain (YW778, lane 2) upholds an 
inferior level ofsurvival to that of the parent strain (YW465, lane1) with 
both DNA damaging agents. This effect is maintained following the 
introduction of pTW340, bearing OGGI (same backbone as pCeapn-l 
constructs) as seen lane 3. Lane 4 reveals that the expression of 
CeAPN-l restores parental resistance towards the repair of the 
respective strand breaks caused by the agents in question. Lanes 5-6 
show that the introduction of the constructs bearing Ceapn-l mutations 
cause a similar level of growth to that observed with YW778. 
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4.0. DISCUSSION 
The discovery of CeAPN-l in C. elegans corresponds to the first member of the 
Endo IV AP endonuclease family to be found in a higher eukaryote, representative of an 
animal model [84]. This particular organism was, in fact, shown to be composed ofboth 
Exo III and Endo IV families; a unique composition that has previously never been 
observed in a multicellular system [84]. Despite the fact that a mammalian member of 
the Endo IV family has yet to be found, it is believed that the study of an enzyme from a 
metazoan model would provide significant clues on the existence of a potential 
homologue in mammals. Such homology would likely arise from a functional rather 
than a strictly structural identity. 
Although the long term goals in the characterization of CeAPN-l rest on in-vivo 
studies, a classical biochemical approach remains primordial in the understanding of 
this enzyme and its true biological role. The approach taken in this study is fundamental 
in the determination of the types of lesions the prote in can directly process, the 
necessity of additional factors for activity and a comparison in the degree of similarity it 
shares with other Endo IV family homologues. As a result, in order to perform a 
classical in-vitro biochemical characterization of CeAPN-l, the first hurdle remains the 
ability to obtain a pure fraction of the protein in question. 
4.1. Utilization of His Affinity Tag 
CeAPN-l was initially decided to be tagged with a His tag due to the fact that it 
IS mu ch smaller than other affinity tags and therefore, less likely to interfere with 
enzyme activity. As mentioned in the introduction, the utilization of a larger tag (GST) 
was believed to negate enzyme function [86]. Evidently, a smaller tag of 6 ami no acid 
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repeats (His) would be less susceptible to directly affect proper prote in folding. It 
should further be recognized that the affinity tag was fused to the N-terminal end of the 
gene of interest; thus, previous studies with corresponding homologue proteins showed 
no inhibition of activity when fusing tags to the N-terminal [79]. 
Despite the creation of the fusion prote in, many difficulties were encountered in 
order to achieve full purity. Routinely, multiple proteins had been observed in collected 
fractions following elution steps. It should be noted that these fractions in question, 
although not homogeneous (multiple signaIs observed in sypro stained gels), did 
demonstrate to be active in repairing damaged DNA (AP sites and 3'-blocked ends). 
The identity of the contaminating bands, observed via sypro staining, may have been 
suggested to be due to particular components binding very tightly to the protein of 
interest. Another hypothesis to explain the excessive banding pattern following column 
elution could stem from the possibility that CeAPN -1 may be undergoing certain post 
translational modifications, which may include its degradation. However, these 
situations were not encountered while studying other proteins of the same family, 
notably, E. coli Endo IV and S. cerevisiae Apnl. As a result, it was strongly believed 
that the contaminating proteins arose from non-specific interactions with the His affinity 
(Talon) resin. Experiments performing a parallel purification using the transformed 
yeast strain expressing CeAPN-1 (YW778 / pCeapn-l) and the untransformed AP 
endonuclease deficient background (YW778) have later proven that the vast majority of 
the contaminating bands can be accounted as being non-specific. 
Numerous approaches and measures had been attempted to achieve full purity 
for subsequent characterization. Thus, extracts were progressively fractionated, pH was 
fine tuned, multiple column resins were exploited and the configuration of the construct 
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was modified (implementing His tag to C-terminal end). Nonetheless, the final result 
commonly yielded very little protein if any and sometimes produced inactive fractions. 
It should be noted that two constant hurdles had been encountered throughout the 
various purification attempts: firstly, the challenge in purifying a prote in that was not 
highly expressed in the system used, and secondly, the inability of the recombinant 
protein to strongly bind to the affinity beads. As a result, new approaches had been 
envisioned to overcome these hurdles by possibly changing expression systems or 
adding another tag to the single tag construct. As a result, very little difficulty was 
encountered using the bacterial system to express and purify the yeast Apnl homologue. 
It should be noted that a similar approach (using E. coli) had been initially adopted for 
the characterization ofCeAPN-l. Nonetheless, the expressed product (20 kDa) obtained 
from bacteria did not correlate with the expected size (30 kDa) and prevented thorough 
characterization from being performed [55]. It was, in fact, believed that the C. elegans 
prote in was truncated through a proteolytic process in the bacterial expression system 
[55]. Consequently, the utilization of insect cells via a baculovirus system was thought 
to be a more viable option to express the recombinant worm protein. This type of 
system has become very prevalent in recent years for the expression and purification of 
specific proteins. In essence, the benefits of insect cells arise from the fact that they 
represent a more advanced eukaryotic system which is able to conduct post translational 
modifications [99]. Moreover, insect cells provide an environment that allows proper 
prote in folding. It is also very important to note that insect cells are known to be able to 
express proteins at high levels [99]. A major disadvantage, however, with the utilization 
of in sect cells lies in the absence of a specific test or assay that permits the evaluation of 
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whether functional cross species complementation can occur with the introduction of a 
foreign gene [61]. 
4.1.1. Utilization of a GST Affinity Tag: 
A second option resided in the preservation of a yeast expression system while 
changing the promoter to optimize the expression level. Moreover, in doing so, it was 
also deemed that the subsequent purification steps may be rendered more efficient by 
fusing an additional GST tag to the His-Ceapn-l or Ceapn-l-His genetic constructs. 
GST tagged proteins are known to be easily purified via a glutathione sepharose matrix. 
Thus, glutathione-S- transferase has a strong affinity for glutathione and allows the 
recombinant protein to bind tightly to the resin while non-specific components are 
washed away. The protein of interest is eluted under mild conditions using reduced 
glutathione. 
Interestingly, a GST system was initially avoided since it was equally utilized in 
the past to purify a recombinant form of the CeAPN-l protein. As a result, the 
introduction of the pGST -Ceapn-l in an AP endonuclease deficient yeast strain 
(YW778) failed to demonstrate complementation and activity. This inability was 
originally believed to be linked to the possibility that the tag may have interfered with 
proper protein folding. However, it was learned only thereafter that the utilized 
construct lacked a key N-terminal do main which resembled very closely a nuclear 
localization signal (NLS). Bence, it was later assumed that the inability of the CeAPN-l 
recombinant to substitute for y Apn 1 was linked more largely on the absence of the 
NLS-like domain rather than the fused GST tag. 
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A P cup copper inducible promoter was exploited to drive the expression of the 
resulting GST-tagged sequence. It should be noted that the His-Ceapn-l fragment was 
recombined into the pTW340 backbone (containing the Pcup promoter and GST tag). 
Evidently, the final expressed product results in a dual tagged protein composed of HIS 
and GST affinity tags. The presence of two affinity tags coupled with the insertion of an 
NLS was thought to concurrently alleviate the purification process and preserve the 
protein activity respectively. Indeed, the dual tagged protein was purified with relative 
ease, in comparison to previous attempts, using a single step approach via the 
glutathione resin. The resulting SDS stained gel revealed the presence of minimal 
contaminating species being co-eluted with the prote in of interest. 
4.2. Activity Assays ofGST Tagged Protein (GST-HIS-CeAPN-l) 
Despite the purity of the collected fraction, in-vitro assays revealed that the 
enzyme lacked activity. Initially, assay conditions were modified by re-evaluating the 
ionic strength and various reaction conditions; however, these efforts did not pro duce 
substrate turnover (data not shown). It should be noted that the crude extracts did 
demonstrate activity, which suggested that the activity of the purified protein may be, in 
fact, lost during the purification process. Accordingly, it was assumed that a possibility 
existed that CeAPN-l may require a particular component to stimulate its activity. 
Thus, extracts from the YW778 strain (AP endonuclease deficient) were introduced to 
the reaction with the purified GST recombinant protein. 
Interestingly, the addition of the AP endonuclease deficient extracts did appear 
to dramatically stimulate the activity capacity of the enzyme. Thus, enzyme activity can 
be observed with the addition of as little as lOng of total extract. Undoubtedly, the 
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presence of the extracts alone (void of AP endonuc1ease) is unable to process the 
damaged DNA being utilized in this assay. 
Further experimentation was performed to assess the observed phenomenon 
causing activity stimulation in the presence of YW778 extracts. Thus, to evaluate the 
possibility that a prote in may be involved in the stimulation of CeAPN-I, extracts were 
rigorously heated (95°C, 5 minutes); thus, inactivating (denaturing) most proteins in the 
extracts. The pre-treated extracts were added in reaction with purified GST-HIS-
CeAPN-1 and assayed for AP endonuc1ease activity. It was believed that the absence of 
activity would promote the notion that CeAPN-1 requires a particular polypeptide to 
ensure AP endonuc1ease activity. 
However, despite the addition of heat treated extracts to the purified CeAPN-1 
fusion prote in, the stimulation of enzyme activity was continued to be observed. Thus, 
collected results revealed a distinct band characteristic of the converted 20mer, 
following the addition of heat treated extracts, which paralleled very c10sely to what 
was observed in the presence of non-heated extracts. The substrate turnover continued 
to increase with the concentration of extracts (up to 1000 ng) while substrate and 
CeAPN-1 levels were maintained. 
The continued stimulation caused by the addition of heat treated extracts allows 
one to conc1ude that a prote in would not likely be the necessary agent behind the 
phenomenon. Larger proteins would be more easy to mIe out since the y are composed 
of multiple folding 'signatures' and consequently, it would be highly improbable that 
they would have the opportunity to re-fold correctly. Thus, a vastly smaller protein, 
consisting of minimal 'folding signatures' may be more capable of promptly re-folding 
into its native state following denaturing conditions. 
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An initial possible candidate that could be causing this activity stimulation may 
be linked to a metal factor. Thus, Exo III family members have showed dependence 
towards Mg2+ ions in order to render these proteins active. It could be assumed that 
CeAPN-1 requires a specifie metal factor for activity which may, in fact, differentiate it 
from other studied Endo IV members in yeast and bacteria. T 0 test this hypothesis, 
YW778 extracts were dialyzed against a buffer free of metal ions and subsequently 
added to reaction with purified GST-HIS-CeAPN-l. Furthermore, a second experiment 
aimed at observing whether any activity stimulation would exist following the addition 
of a fixed concentration of metal ions (increasing concentration) in reaction with the 
purified recombinant protein. 
As seen with heat treated extracts, the addition of dialyzed extracts maintained 
an ability to stimulate the catalytic function of the recombinant protein. Moreover, the 
addition of individual metal ions, notably, Zn2+, C02+, Mn2+, did not demonstrate any 
ability whatsoever to positively affect enzyme activity. Therefore, it could be suggested 
that divalent metal ions are probably not responsible for the stimulation of CeAPN-l 
activity. 
4.3. Conclusions Stemming from Activity Assays: 
Preliminary data suggests that CeAPN-l requires a particular component to 
increase ils activity level. This phenomenon was revealed by the addition of YW778 
extracts to purified protein during activity assays. The stimulus was originally thought 
to be linked to three possible candidates: a metal factor, protein or DNAIRNA (not 
investigated in this study). No indication has thus far been observed to indicate that a 
metal ion is causing the activity stimulation. As highlighted above, experiments 
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utilizing dialyzed extracts and the addition of individual factors (Zn2+, C02+, Mn2+) with 
a purified fraction of CeAPN-l failed to convey that a metal ion is implicated. A 
probable candidate could be a very small prote in comprised of heat stable properties. 
Although, the addition of boiled extract to purified protein was not shown to reduce the 
extent of activity stimulation, this does not entirely refute the possibility that a protein 
may be at play. Thus, a prote in candidate would have a low molecular weight and the 
ability to regain its native form immediately following significant thermal treatment. As 
a result, the exact role or mechanism governing this overall process is unknown. If a 
prote in is involved, it must have sorne role in allowing GST-CeAPN-l to access the 
lesions in question with greater ease. It is unlikely that pH or buffer composition is the 
cause of this phenomenon; however, additional experimentation is required to fully rule 
out these possibilities. 
Interestingly, it is widely documented in the literature that certain proteins 
require small molecular weight polypeptides or nuc1eic acids for their activity. In fact, 
Ruzindana-Umunyana et al. 2000 has reported that adenain, a cysteine protease 
responsible for uncoating and virion maturation in adenoviruses, requires an Il amino 
acid peptide cofactor in order to stabilize its optimal conformation for enzyme function 
[100]. In another report, it has been similarly demonstrated by Abdel-Ghany et al. 1984 
that a polypeptide is needed for the activity of a prote in kinase present in the plasma 
membrane of Ehrlich ascites tumor cells. The activating component was shown to be 
heat stable and believed to be identical to histone 1 [10 1]. 
An interesting experiment to shed light on the activity stimulation would be via 
the utilization of a potent protease (i.e. trypsin) to c1eave aIl proteins present in the 
YW778 extracts. The treated extracts could thereafter be boiled, added to purified 
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recombinant forms of CeAPN-1 and finally, assayed for activity. As a result, the 
absence of activity would promote the notion that a prote in is indeed involved. 
Measures may be devised to isolate the prote in in question by running the extracts in a 
series of purification columns (i.e. anion exchange, gel filtration) and evaluating the 
presence of AP activity following each step. Ideally, once fully purified, the protein 
may be sent for mass spectrometry analysis in order to identify the component in 
question. It would also be intriguing to use heat treated extracts stemming from 
different models (i.e. mammalian cells and bacteria) to observe if stimulation is 
maintained following the addition of purified protein. Thus, an important evaluation to 
perform would lie in the demonstration of wh ether worm extracts deficient in AP 
endonuclease activity are able to confer activity stimulation. The confirmation of 
protein involvement would subsequently make the utilization of siRNA an interesting 
approach. In essence, this technique would allow one to observe the extent at which 
worms can counter DNA damage in the absence of this particular prote in that may be 
involved. 
Nonetheless, the continued presence of activity following the addition of 
protease/heat treated extracts may indicate that the stimulation is the result of other 
possibilities. DNA and RNA may become potential candidates triggering the dual 
activity stimulation of the recombinant prote in. One can suggest that the nucleic acids 
may bind to the prote in and contribute to changing the conformation of the polypeptide. 
Nucleic acids have been observed to be an important component for the activity of 
particular proteins. Such is the case demonstrated by DNA prote in kinase (DNA-PK), a 
nuclear serine/threonine kinase, which requires double stranded DNA for its activity 
[102]. The possibility of nucleic acids being required by CeAPN-1 could be analyzed 
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directly by separately incubating the YW778 extracts with DNase and RNase and 
thereafter, evaluating whether the addition of the treated sample with purified CeAPN-l 
stimulates AP endonuclease activity. 
As discussed in the introduction Endo IV members have been shown to be 
multifunctional. Although not completed during this specific experimental trial, it 
would undoubtedly be an interesting goal to assess whether CeAPN-l is also equally 
endowed with such activities (i.e. NIR and 3'~5' exonuclease). Moreover, having 
showed the possibility of a thermally stable component stimulating AP endonuclease 
function, this would naturally raise the question of whether this phenomenon is 
consistent with the other biological activities associated with Endo IV members. 
4.4. Domain Function Analysis: 
Close inspection of the E. coli endo IV crystal structure has allowed one to 
recognize that the N-terminal and C-terminal portions of the prote in are fairly close to 
each other [68]. The active site is composed ofpositively charged amino acids (arginine 
and lysine residues) and a cluster of Zn2+ ions which forms the positive core (within the 
groove) that grants entry to the negatively charged DNA strand. The most conserved 
region of amino acids shared between the various Endo IV family members is known to 
be located between residues Asp 179 and His182 [68]. The structural data appears to 
suggest that this group of amino acids provides stabilization to the beta barrel and, in 
turn, to the tri-nuclear zinc cluster [68]. 
Site directed mutagenesis studies have been performed with the yeast Apn 1 and 
the bacterial en do IV proteins [88, 93]. Although fairly conserved, two particular 
mutations have shown that the yeast protein differs from its bacterial counterpart. 
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Hence, a variant of the yApnl protein, specifically consisting of an ammo acid 
substitution of the Glu158 residue with Gly, yielded a 150 fold decrease in activity [88, 
93]. Nonetheless, additional experiments have showed that the E158G variant does 
retain an ability to bind to DNA [88]. Interestingly, the corresponding variant form of 
endo IV, E145G, also showed a 150 fold reduction in enzymatic activity but revealed no 
capacity for DNA binding [93]. Consequently, it is believed that the E145 residue in the 
endo IV protein has a dual role involved in both catalysis and substrate binding [93]. 
The equivalent residue, E158, in yeast Apnl may, in contrast, be solely involved in 
enzymatic activity via its coordinationof the specific zinc ion [88]. 
As a result, as mentioned earlier, one of the principle goals of this study wished 
to investigate the structural and domain features CeAPN -1 shares or differentiates it 
from its counterparts. Undoubtedly, having 44.9 % ami no acid identity with the E. coli 
endo IV, the structure of CeAPN-l is thought to resemble very c10sely that of its 
bacterial homologue [84]. As a result, the Swiss Model application enables an 
interesting rough visualization of the C. elegans protein based on its homology to endo 
IV. The pro gram confirms a strong likelihood that CeAPN -1 is also composed of 
similar features which inc1ude a structure of 8 alpha helices and 8 beta strands believed 
to be essential in substrate binding and a fairly large pocket for catalysis [68, 94, 96, 
97]. 
In this analysis, two variant proteins were produced and compared to the C. 
elegans native protein and the other homologue variants (yeast and bacteria). Thus, the 
first amino acid substitution was conducted at the Asp143 (EI43) position to produce 
Glycine143 (EI43G). The E143 residue was chosen due to the fact that it was thought 
to be a key player in the coordination of the Zinc c1uster found in the active site [68]. As 
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described earlier, substitution of the corresponding residue in the bacterial endo IV 
(E145G) and yeast Apn1 (E179G) has produced interesting data to demonstrate a 
divergence of the respective homologue proteins and the individual roles the residues 
play in catalysis and DNA binding [93] [88]. Thus, it would be. intriguing to 
demonstrate whether the worm homologue resembles more the bacterial endo IV or the 
yeast Apn 1 counterpart. 
ln addition, a second amino acid substitution was conducted at the E97 position. 
Very little is actually known about this particular residue despite the fact that is found in 
the first conserved do main amongst the Endo IV member sequences. Hence, unlike 
E143, corresponding mutations have not been conducted while studying bacterial endo 
IV and yeast Apn 1. Moreover, a compelling aspect justifying the investigation of E97 
arises from its distinct features. Along with R95, it is the only charged residue which is 
found in homology region 1 that is conserved in aIl four models (E. coli, S. pombe, S. 
cerevisiae . and C. elegans) (referred to the alignment given in [55]). Two separate 
amino acid substitutions found in the first conserved region, S87P and C98R (via 
chemical mutagenesis), have been conducted using E. coli endo IV [93]. Interestingly, 
the introduction of the former variant (S87P) in an AP endonuclease deficient strain has 
shown to cause partial complementation in the presence of specifie DNA damaging 
agents. On the other hand, the latter alteration, C98R, fails to cause any 
complementation under the same conditions [93]. However, the Ceapn-1 sequence, 
unlike what is observed in S. cerevisiae and E. coli, does not contain a corresponding 
Cysteine but an Alanine residue (refer to alignment given in [55]). 
Preliminary results coIlected following the introduction of the E143G mutation 
to the C. elegans gene, via site directed mutagenesis, is in accordance with what was 
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reported with the yeast and bacterial variants [88, 93]. A gradient plate assay, in fact, 
indicated that a strain with the introduced E143G mutation was unable to complement 
for yApnl when exposed to an increasing concentration of MMS. It should be noted 
that a Western Blot analysis revealed that the E143G variant was being stably 
expressed. Unfortunately, further work was not conducted due to the inability to pur if y 
to homogeneity a sufficient amount for subsequent characterization studies. 
In contrast, the E97G variant was not detected at its expected size via Western 
blot analysis by the anti-GST antibody (presence of lower molecular weight bands 
reacting with antibody may be indicative of degradation). The failure to identify the 
presence of E97G (at predicted molecular weight) could be due to the nature of the 
substitution which may be causing a dispersal of the acidic cluster surrounding the 
residue; consequently, producing a structural instability leading to the protein's rapid 
degradation. 
4.5. Conclusion and Future Perspectives: 
Deficiencies in DN A repair processes are known to trigger the onset of disease 
and aging in humans. BER is one of the most important repair pathways since it takes 
part in the processing of the most common insults affecting DNA. Despite the fact that 
repair mechanisms overiap in terms of their functions, defects in specific components of 
BER have been correlated to impairing survival. In humans, defects in the glycosylase, 
MYH, has been linked to familial adenomatous polyposis and multiple colorectal 
adenomas (with or without carcinoma) [103, 104]. Studies have as well indicated a 
susceptibility to cancer in subjects having abnormal variants of the Pol~ prote in or loss 
of the OGG 1 genetic locus [105-107]. Alternatively, much has yet to be learned 
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concerning the polymorphic variants of the human AP endonuclease, APE1 (Exo III 
family). Although, it has been reported that such variants have been correlated to 
impairing normal functioning, its precise association to cancer is still not clearly 
displayed [108, 109]. However, it should be noted that APEI haploinsufficient mice 
have been documented to have high spontaneous mutagenesis, increased tendency 
towards cancer and, consequently, decreased survival. The APE1 double knockout 
mouse, in contrast, is embryonically lethal. Undoubtedly, the continued study of BER 
and its various components is believed to enhance our understanding of various diseases 
such as cancer [110, 111]. 
4.5.1 The Study of a C. elegans Protein 
The finding of APN-l in C. elegans represented the first member of the Endo IV 
family to be found in a multicellular animal model. Although, a human structural 
homologue of the Endo IV family has not been discovered yet, it is believed that a 
functional counterpart does indeed exist [55]. Thus, the characterization of an APN-I 
member stemming from a metazoan model was believed to serve as a first step to 
potentially provide clues concerning a possible functional human homologue. 
Interestingly, such a study involving the C. elegans protein could pro vide additional 
insight on the corresponding Endo IV protein in the malaria parasite Plasmodium 
falciparum. Better understanding of the AP endonuclease enzyme could enable the 
elucidation of a pathway in the parasite that may serve as a potential therapeutic target 
against malaria [112]. 
Furthermore, the characterization of the C. elegans protein was also thought to 
shed sorne light on DNA repair mechanisms associated with the multicellular organism. 
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Contrary to bacteria and yeast, the worm model has, in fact, not been as widely utilized 
in the study of DNA repair. Increased awareness of C. elegans may potentially promote 
its value as a modellmarker for environmental toxicity studies [113]. 
4.5.2 Future Work 
The work conducted in this study serves as a first step in the understanding of 
CeAPN-l. Thus, this particular investigation sought to characterize CeAPN-l in-vitro 
through c1assical biochemical means. It was found that the functional activity of the 
polypeptide may be stimulated via an extra component. The identity of this molecule, 
however, remains to be fully determined. As highlighted earlier, via the means of 
purification and mass spectrometry, one could potentially identify or at least better 
understand the process causing this particular enhancement in activity. 
The next step, beyond this specific study, lies in the in-vivo characterization of 
the protein. Hence, a major objective in this type of investigation consists in 
demonstrating how mutations may accumulate in worms spontaneously and when 
exposed to DNA damaging agents when CeAPN-l and CeEXO-3 expression is 
individually repressed. This worm response could be compared to a situation of dual 
repression involving both AP endonuc1eases. 
Furthermore, as explained in the introduction, it should be stressed that Ceapn-l 
is composed of a large N-terminal domain (118 residues) which distinguishes itself 
from the other members of the Endo IV family in two aspects. Thus, the N terminus 
region is thought to act as a nuc1ear localization signal which is indicated by the highly 
concentrated presence of basic residues (characteristic ofNLS) [87]. Unlike yeast Apnl, 
having a bipartite NLS at the C-terminus, the C. elegans protein may be composed of an 
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NLS found at the N-terminus [78]. Moreover, the presumed NLS region within the 
Ceapn-1 gene appears to differentiate from its counterpart in its sheer size of 
approximately 118 amino acids. The large size of this domain suggests that it may play 
a broader role than first thought (acting solely as a nuclear localization signal). Renee, 
the domain might play a role in recognizing or accessing lesions as weIl as possibly 
being implicated in targeting the protein to different organelles (i.e. the mitochondrion) 
[79]. The investigation of the N-terminal domain could begin by exploiting GFP tagged 
constructs and analyzing the localization of the expressed product in worms through 
fluorescence microscopy [79]. One could also create mutations within the N-terminal 
domain to characterize the key residues and confirm the fundamental underlying 
importance of the region [78]. 
Being a DNA repair protein, it would also be interesting to determine if CeAPN-
1 is able to associate to other proteins, notably transcription factors or other components 
of BER. Such interactions would not be out of the realm of possibility; in fact, the 
human AP endonuclease, Ape 1, has been in fact correlated to interact with, amongst 
others, PCNA and specifie glycosylases (MYR) [34]. Moreover, previous studies have 
shown yApnl interacting with Pirl for transport into the mitochondrion [79]. As a 
result, an analysis in search of similar phenomena may be designed using a series of IP 
experiments with C. elegans extracts. 
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